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ABSTRACT
ENDOTHELIAL NITRIC OXIDE SYNTHASE AND GROWTH FACTOR
REGULATION OF FLOW-MEDIATED VASCULAR REMODELING
David Anthony Tulis
Old Dominion University and Eastern Virginia Medical School
1997
Director Dr. Russell L. Prewitt

This study was designed to characterize structural remodeling of male Wistar rat
mesenteric arteries exposed to elevated blood flow in vivo for 1, 3, or 7 days. A series of
arterial ligations induced blood flow increases in ileal and second-order branch arteries
compared to same animal control vessels. Neither mean carotid nor local mesenteric
arterial pressures changed significantly pre- to post-ligation. The primary flow-mediated
force in both vessels was shear stress with possible involvement of acute stretch-induced
wall stress in the ileal artery. Significant luminal expansion and medial wall hypertrophy
occurred in the ileal and second-order arteries in a time-dependent fashion. Increases in
extracellular connective tissue occurred concomitantly with arterial remodeling.

Wall

thickness to lumen diameter ratios did not change in any vessel at any time when
compared to controls, suggesting normalization o f flow-induced wall stress through
vascular remodeling.
Immunostaining for proliferating cell nuclear antigen and nuclear profile analyses
indicate that both medial SMC and intimal EC hyperplasia contribute to flow-induced
remodeling o f the vessel wall. Immunostaining for eNOS suggests its upregulation in
response to elevated flow at all time points. Results from in situ hybridization reveal
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significantly elevated PDGF-A mRNA expression in the media after 24 hours and in the
endothelium after 3 and 7 days. Medial wall and endothelial expression of bFGF and
TGF-31 were negligible in both control and high flow vessels at all time points. Basal
levels o f PDGF-B transcripts were detected in control and high flow vessels, with no
significant differences between the two groups. The findings from this study suggest flowstimulated arterial remodeling in vivo involves SMC and EC hyperplasia and increases in
extracellular connective tissue. This vessel wall restructuring may involve the actions of
NO and PDGF-A as regulators o f flow-stimulated growth; however, bFGF, TGF-fll, and
PDGF-B do not seem to be involved.
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I

CHAPTER!
INTRODUCTION
Regulation o f arterial tone, structure, and growth is accomplished through a
variety of endogenous biochemical and biophysical factors.

Vasoactive chemical

mediators of vascular physiology include eicosanoid products, endothelial-derived relaxing
and hyperpolarizing factors, mitogenic growth factors, angiogenic growth promoters and
inhibitors, and autocrine and paracrine cytokines.

Biophysical mechanical factors

regulating vascular physiology include two primary hemodynamic forces: shear stress and
circumferential wall stress. These various chemical factors and biomechanical forces help
maintain normal vascular homeostasis as well as influence vascular growth and remodeling
during angiogenesis, vasculogenesis, apoptosis, and vessel rarefaction.

Alterations in

these parameters, however, have been implicated in the development of vascular
pathologies such as localization of atherosclerotic foci, pathogenesis o f intimal and
subintimal neoplasias, development of systemic hypertension, and diabetic microvascular
disease. In an effort to further understand the contributions o f biophysical mechanical
forces and biochemical mediators on vascular pathophysiology, this research project
characterizes the adaptive responses of rat small mesenteric arteries exposed to in vivo
increases in blood flow under normotensive conditions. The relative contributions of the
two primary flow-mediated hemodynamic forces in stimulating arterial remodeling will be
assessed using a unique in vivo experimental model. Complete histologic and cellular
analyses will be made o f the gross morphological alterations induced by these stresses, and
elucidation of the possible signal transduction and transmission pathways will be made
through in situ hybridization and immunocytochemical approaches. The results from this
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study will further characterize blood flow-associated stresses and their impact on
biochemical signaling as endogenous stimuli capable of inducing arterial remodeling under
in vivo conditions.
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CHAPTER D
BACKGROUND AND LITERATURE REVIEW
Arterial Anatomy and Physiology
The arterial cross-section is composed of the intima, primarily an EC monolayer,
the media, the muscular wall of the artery composed o f SMC surrounded by an internal
and external elastic laminae, and the adventitia, a dense collagenous structure containing
bundles of collagen fibrils, elastic fibers, some SMCs and many fibroblasts. The EC layer
is anatomically located between luminal blood flow and the underlying smooth muscle and
extracellular components; therefore, the endothelium functions as a mechanically sensitive
signal transduction interface between hemodynamic stresses and the vasoactive smooth
muscle layer. On the basal aspect of the endothelium lies the extracellular matrix o f the
basement membrane, which is composed of four major classes of macromolecules:
collagens, elastins, proteoglycans, and structural glycoproteins (89). The ECM functions
to influence EC adhesion, spreading, migration, protein synthesis, proliferation, and
differentiation (reviewed in 175). Other functions of the endothelium are maintenance o f
anticoagulant non-thrombogenic properties, control of lumen diameter and tissue
perfusion, regulation of vascular permeability, metabolism of vasoactive substances,
production of connective tissue and growth factors, and initiation of signal transduction
cascades stimulated by acute inflammation, wound healing, and localization o f
atherosclerotic foci (35, 154).
The media is composed of SMCs oriented radially around the vessel
circumference. Primary roles for the SMC layer include maintenance of arterial tone,
synthesis of connective tissue and cholesterol, lipid metabolism, and reaction to vasoactive
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agents through vasodilation or constriction (154). In both cell culture and the intact wall,
SMCs can express two different phenotypes: a synthetic phenotype in which secretion is a
primary function, and a contractile phenotype which is associated with vessel contraction
and relaxation. Morphological alterations in the vascular wall from hypertension (95),
atherosclerotic intimal thickening (54), and flow-mediated wall remodeling (179) primarily
involve growth and proliferation o f medial SMCs.

Individual ECs and SMCs are

surrounded by extracellular connective tissue, comprised of similar components as the
ECM at the EC-SMC interface. The extracellular connective tissue is involved in cell-cell
signal transmission and syncytial cellular coordination. The outlying adventitia contains
many lymphatic channels and nerve fibers that help innervate the vessel wall.

The

adventitia is also highly vascularized and provides the vessel wall with nutrients as well as
growth factor and cytokine production (154).
Arterial Remodeling
Vessel wall remodeling can be broadly defined as any reorganization o f wall
components involving both increases and decreases in wall area.

Remodeling can be

viewed in terms of 1) gross network changes involving alterations in vessel length,
vasculogenesis and/or angiogenesis, vessel arborization, and vessel rarefaction; or 2)
organizational changes involving medial wall hypertrophy, intimal thickening, luminal
enlargement, and ECM and/or connective tissue restructuring.

Cellular mechanisms

behind these gross morphological changes can include EC and SMC hyperplasia, cellular
hypertrophy, cellular migration, cell lysis and death or apoptosis (32). Changes involving
nuclear ploidy may also occur consistent with alterations in cell mass. Remodeling is an
active process that enables the vessel to accommodate to changes in the local environment
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in order to maintain normal vessel geometry and tissue perfusion (160). Control o f arterial
remodeling is multifactorial and depends on factors such as cytokines, growth factors,
neurotransmitters, hormones, autacoids, and mechanical forces (32). This multifactorial
control, however, predisposes remodeling to be incongruous throughout the vasculature.
Inter- and intra-vascular heterogeneity o f structural remodeling has been examined in
experiments using whole animals, cultured cells and organs, and in models of arterial
injury and hypertension (reviewed in 32).
Biophysical Forces in the Vasculature
Biophysical forces in the vascular system can be described as stresses acting upon
cellular and extracellular components o f the vessel wall. Stress is defined as any force
acting per unit area, and in the vasculature may be manifested as pressure and compression
acting normal to a surface, frictional shear at the surface, and opposing tensile stresses
acting outward from the surface (39). Circumferential wall stress, or hoop stress (o), acts
normal to the cell surface and creates a force in a circumferential direction on the crosssection o f the vessel.

This compressive force is sensed primarily by the elastic,

collagenous, and smooth muscle load-bearing components o f the subendothelial wall.
Using the LaPlace relation and assuming isotropic conditions exist in the vessel wall,
circumferential wall stress is directly proportional to wall tension [the product of
transmural pressure (P) and vessel inner radius (r)] and inversely proportional to vessel
wall thickness (w). The equation for circumferential wall stress is a = Pr/w; therefore,
under conditions o f increased pressure, wall stress can be normalized through an increase
in vessel wall thickness (36, 109). In addition, if local pressure is held stable, luminal
enlargement concomitant with increases in medial wall thickness can offset any changes in
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wall stress. Estimates for wall stress in arterioles and venules range between 0.5 - 10 x
10s dynes (dyn) per square centimeter (cm2 ; ref. 165).
In comparison, shear stress (t) is a frictional, tangential force exerted by blood
flow on the luminal aspect of intimal ECs in the same direction as blood flow. This stress
is sensed primarily by intimal ECs which can transfer this stimulus into internal stresses
that may be transmitted to abiuminal sites o f attachment or to neighboring ECs through
biochemical cascades or cytoskeletal activation. Transduction o f these stresses to the
underlying smooth muscle layer or to adjacent ECs may occur through mechanicallysensitive focal adhesion sites (38) and/or through metabolic and electrical coupling via gap
junctions (36). In addition, medial SMCs have been found to be directly exposed to shear
stress through interstitial fluid flow movement (3). Using the Poiseuille-Hagen relation
and assuming complete laminar flow with a Reynold’s number less than 2000, wall shear
rate (y; sec'1) is directly proportional to fluid volume flow (Q) and inversely proportional
to the vessel radius (r). The equation for WSR is y = (m + 2)Q/7tr3. The dimensionless
factor m depends on flow conditions: m = 2 for laminar flow and m > 2 for turbulent flow
(145). For conditions of constant fluid viscosity (p.), shear stress is proportional to WSR.
The equation for laminar shear stress, therefore, is
dyn/cm2.

t

= 4Qp/7tr3, and is measured in

These equations indicate that under conditions of increased flow, a small

increase in radius can restore WSR and shear stress to normal values. However, if vessel
radius is held constant during periods o f increased flow, a direct increase in shear stress
occurs. Luminal shear stresses have been measured as negative values in regions of flow
reversal, < 1 dyn/cm2 in veins and in regions o f flow separation, and > 100 dyn/cm2 at
bifurcations of larger arteries or during episodes of increased cardiac output or
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hypertension (35, 36, 145).

Shear stresses from interstitial fluid movement surrounds

medial SMCs and have been calculated to range between 1 (188) and 10 dyn/cm2 (2).
Homeostatic arterial luminal mean shear stress is continuously regulated through
endothelial-dependent vasodilation at approximately 15 dyn/cm2 (109), which produces
the lowest energy cost for propelling blood volume through a branched network.
In a homeostatic vascular system, blood flow is generally laminar with constant
and predictable shear stresses.

However, in areas of non-uniform geometry where

arborization, bifurcations, and curved regions occur, flows tend to separate forming
vortices and eddies characteristic of turbulent flow.

In these regions, the frequency,

magnitude, and direction of blood flow become chaotic, and shear stresses can fluctuate
greatly and even form negative values in regions of flow reversal (36). Under transitional
flow conditions, with Reynold’s numbers between 2000 and 3000, disturbed laminar flow
can occur with complex flow lines and a wide range of shear stresses. Consideration of
these various forms of blood flow is necessary when studying shear stresses in different
levels of the vasculature. In addition, large conduit arteries convey blood flow that is
pulsatile, corresponding to systole and diastole of the cardiac cycle; therefore, large
vessels are exposed to a range o f shear stresses and stress gradients when compared to the
steady flows found in the smaller arteries and in the microcirculation.

Nevertheless,

Barbee et al. (12), using atomic force microscopy to study the luminal surface of
endothelial cells exposed to varying flow conditions, defines blood flow as “quasi-steady”
and approaching laminar near the EC luminal plasma membrane even in pulsatile large
artery flow.
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Studies on Flow-mediated Vascular Remodeling
The influence o f blood flow on the vascular system has been studied for over a
century. Thoma, in 1893, found a significant correlation between the diameter o f a chick
embryo vessel and the blood flow that it conveys (referenced in 59, 77).

Thoma

discovered that, during angiogenesis, blood vessels with the fastest blood flow rates
became the dominant arteries while the vessels with slower flow rates constricted and
eventually atrophied. Early works by Schretzenmayr, Fleisch, and Hilton (referenced in
166, 168) attributed flow-induced dilation during functional hyperemia in large arteries to
a vascular reflex or to a conducted process through the vessel wall.

Other early

investigators studied the influence o f blood flow on the state of constriction o f vessels
using various models such as arteriovenous fistulas (63, 144) and vasculogenesis and
angiogenesis in the collateral circulation (100, 190). In 1975, Rodbard suggested that the
endothelial layer of arteries senses increased blood flow and releases a vasodilating
substance that acts on the medial smooth muscle to cause dilation (152). More recent
studies using various in vivo and in situ models have determined that a significant
correlation exists between blood flow and the extent of vessel dilation (67, 91, 92, 114,
139, 167, 168).

More specifically, the degree of constriction o f an artery has been

determined to be inversely proportional to the blood flow conveyed through it.
Arterial ECs are the primary sensors for the fluid flow shear stress stimulus acting
to regulate flow-induced vascular dilation. Smiesko et al. (167), using a canine femoral
arteriovenous shunt model whereby femoral artery blood flow could be manipulated,
showed a marked 15.8 + 2.7% increase in femoral artery diameter when blood flow
increased from 10 to 293 ml-min'1.

The response time for complete dilation was
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approximately 80 seconds, and was preceded by an initial constriction o f the vessel for
approximately IS seconds.

After the luminal endothelium was removed by a balloon

technique, the flow stimulus failed to cause any significant dilation response. The authors
found that removal o f the endothelium did not cause the artery to lose its basal tone, and
concluded that based on their model using large conduit femoral arteries, an intact
endothelium is necessary to permit flow-mediated arterial dilation. Similarly, Pohl et al.
(137), using a canine femoral arteriovenous shunt model, induced approximately a 5-fold
increase in femoral blood flow resulting in a transient latent response period followed by a
significant vasodilation response in the presence o f normal pressure. This response was
completely abolished by both mechanical removal o f the endothelium (via balloon
catheter) and by chemical inactivation of the endothelium (via hydrogen peroxide
treatment).
Hull et al. (67), using femoral-external jugular and saphenous artery-external
jugular arteriovenous shunts in dogs, induced a 10-fold increase in blood flow causing
significant 9% and 15% increases in femoral and saphenous artery diameters, respectively.
These dilation responses consisted of transient decreases in arterial diameter
corresponding to an initial drop in pressure, followed by rapid relaxation o f the vessels in a
manner proportional to the blood flow increase. A significant decrease in femoral arterial
pressure occurred upon establishment of the arteriovenous shunt; however, this decrease
in transmural pressure was found not to affect the dilation response. Also, an increase in
pulse pressure was observed in this model, but this was also determined not to affect the
response.

Upon removal of the EC layer through mechanical rubbing, neither vessel

dilated under increased flow conditions, suggesting a direct endothelial-dependent flow-
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induced dilation in these large vessels.

Inhibition o f phospholipase A2 by quinacrine

attenuated the dilation response in a dose-dependent manner; however, cyclooxygenase
inhibition through indomethacin treatment did not affect the response.

These results

indicate that the flow-mediated relaxation o f large vessel smooth muscle is related to
activation of phospholipase A2, and may involve a non-prostaglandin metabolite of
arachidonic acid.
In a similar study, Kaiser and Sparks (76), using the same femoral-external jugular
and saphenous-external jugular arteriovenous shunt model in dogs, further characterized
the influence o f the endothelium on flow-dependent arterial dilation. A cyclooxygenase
and lipoxygenase blocker, 5,8,11,14-eicosatetraynoic acid (ETYA), caused irreversible
inhibition of flow-induced dilation as well as significantly increasing the ED50 for
acetylcholine-induced relaxation; however, indomethacin did not affect the dilation
response. Exposure o f the femoral and saphenous arteries to methylene blue, an inhibitor
of guanylate cyclase activation, caused a dose-dependent decrease in the dilation response
to flow.

These results suggested that both cyclic GMP and a non-prostaglandin

lipoxygenase-dependent arachidonic acid metabolite are involved in the response to flow.
Based on the results using an H-l receptor antagonist tripelennamine, these authors
believe that increased blood flow stimulates a local increase in histamine which binds to
the H-l receptor and increases phospholipase A2 activity. This initiates a cascade of
events leading to endothelial production and release of a non-prostaglandin arachidonic
acid metabolite. This metabolite, in turn, stimulates EDRF which activates a vascular
smooth muscle guanylate cyclase to increase cyclic GMP resulting in large vessel
relaxation.
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Comparable studies have been performed investigating the significance of reduced
blood flow on large vessels. Guyton and Hartley (58) used flow-restricting silver clips in
vivo to alter unilateral carotid blood flow in juvenile rats. After 6 weeks o f development,
carotid arterial diameters increased 36% on the flow-restricted side and 62% on the
contralateral control artery.

After 12 weeks o f development, changes were not

significantly larger than at the earlier time point o f 6 weeks.

Overall flow reduction

averaged 35% corresponding to an overall decreased diameter growth averaging -10.2%
of the contralateral control carotids.

Cross-sectional area o f the tunica media was

significantly reduced on the flow-restricted artery, yet the medial area to circumference
ratio (which is proportional to vessel wall thickness) did not change. These results infer a
direct relationship between blood flow, vessel dilation, and vessel wall growth in
developing rats.

Additionally, these authors found that the flow-induced changes

correlated best with net changes in flow pulsatility and were not correlated with changes
in mean flow velocity. They suggest that oscillatory shear stress is the primary force
leading to flow-mediated arterial changes. Langille et al. (91) compared the adaptive
responses o f external carotid arteries following 70 - 80% flow reductions in weanling and
mature rabbits. After 1 month o f flow restriction (-79%) in the presence of normal arterial
pressure, young rabbits experienced significant reductions in ipsilateral carotid artery DNA
levels (-35%), elastin content (-38%), wall mass (-30%), and internal diameter (-31%)
when compared to contralateral control carotid arteries. In mature rabbits, a decrease in
intimal endothelial cell number (-15%) after 1 month and a decrease in internal diameter (21%) of the ligated carotid artery was observed at 1, 2, and 4 weeks after flow
obstruction, yet no significant differences were seen in medial or adventitial constituents.
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These authors suggested that blood flow alterations occurring during weanling
development may modulate proliferation o f cellular and extracellular vessel wall
components as well as normal flow-mediated dilatory responses. Pharmacologic
interventions indicated that adult responses to decreased flow may involve two phases: a
transient, papaverine-sensitive response, vasoconstrictor in origin, followed by a sustained,
papaverine-insensitive structural reduction in diameter consisting o f cellular remodeling.
Treatment with indomethacin and captopril implied that neither prostaglandins nor a local
renin-angiotensin system were involved in these responses. Also, manipulation of local
flow conditions indicated that vessel responses were consistent only with changes in mean
flow velocity, not pulsatile flow.
In a similar study by Langille and O’Donnel (92), ligation of the left external
carotid artery yielded a 70% reduction in common carotid blood flow in rabbits with no
significant change in flow through the contralateral common carotid. After 2 weeks o f
flow restriction, the reduced flow vessel exhibited a 21% decrease in lumen diameter when
compared to the normal flow contralateral artery. Results from papaverine administration
suggested that the reductions in carotid diameter after 2 weeks of flow reduction may
reflect structural remodeling of the arterial wall rather than prolonged constriction of the
medial smooth muscle. Complete abolition of the diameter reduction from diminished
flow occurred upon removal of the intimal endothelial layer by both mechanical (balloon
catheter) and chemical (Triton X-100) methods. These results support the vital role for
intimal endothelium in sensing flow alterations and relaying the message for medial smooth
muscle dilatory responses.

In a more recent study from the same laboratory (186),

common carotid artery ligation resulted in an 80% decrease in flow through the ligated
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artery, corresponding to a 73% decrease in calculated shear stress. This reduced EC
density by 33%, coincident with an 18% decrease in diameter after S days. This vessel
also exhibited a substantial number o f monocytes adhering to the endothelial surface at
cell-cell junctions which appeared to be migrating across the endothelium into the
subintimal space. This may be significant since monocyte adherence and transmigration,
and subsequent differentiation into macrophages, are early events in the atherogenesis
process.

The contralateral carotid artery exhibited a 123% increase in blood flow,

corresponding to a 170% increase in calculated shear stress. The contralateral carotid,
despite these large increases in flow, did not significantly dilate after 5 days, and luminal
EC density was not altered when compared to sham controls. Considering the studies
discussed above, the vital role of luminal ECs in mediating the direct dilatory responses
from high flow conditions in large conduit vessels is substantiated.
In addition to the investigations described above on large conductance and feed
vessels, other studies have addressed the impact o f flow on smaller microvascular arteries
and resistance arterioles. Smiesko et al. (168), using rat mesenteric arcading arterioles
(control lumen diameters 40 - 110 pm) exposed to increased blood flow velocity (-570%)
through collateral circulation in vivo, found a significant 70% flow-dependent vasodilation
after a short latent period. The dilation response lasted for the duration of the experiment
(-10 min), and was significantly correlated with red blood cell velocity, blood flow
volume, and calculated WSR. Arcading arteriolar WSR increased from 722 sec*1 to 5156
sec*1with establishment of the collateral circulation pathway. These authors proposed that
there may not be a controlled stable set point for WSR in mesenteric arcading arterioles.
Roller and Kaley (84), using parallel occlusions in third-order arterioles of rat
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cremaster skeletal muscle (mean control diameter 22.5 pun), induced a 230% increase in
calculated arteriolar blood flow in the presence of normal arterial pressure. This resulted
in an immediate 87% increase in calculated WSR and, following a brief (6 - 15 sec) latent
period whereby diameter actually decreased, a significant 31% increase in arteriolar
diameter. This increase in vessel diameter subsequently decreased the calculated WSR to
approximately 46% over that of controls. In the presence of an intact endothelium under
control flow conditions, the distribution o f data was monotonic and calculated WSR was
not correlated with arteriolar diameter. This suggests that during normal homeostatic
conditions, WSR, and therefore shear stress (in the presence of stable blood viscosity),
may be a controlled parameter in skeletal muscle microvascular networks. In addition,
during periods of increased blood flow velocity, flow-dependent dilation occurs to
regulate shear stress towards a pre-determined set point.

Local impairment o f the

vasoactive functions of the endothelial layer through mercury light-sodium fluorescein
(light-dye) treatment resulted in a slight decrease in control lumen diameter with a
subsequent 36% increase in control calculated WSR when compared to control values
with an intact endothelium. Arteriolar occlusion and increased flow showed complete
abolition o f the flow-induced dilation, corresponding to a highly significant 290% increase
in calculated WSR This increased WSR was not regulated or compensated for (through
dilation) as when the endothelium was intact, supporting a role for endothelial regulation
of WSR (and shear stress) in the microvasculature.
Comparison between flow-induced alterations in normal versus spontaneously
hypertensive rats was performed by Qui et al. (139) on mesenteric conductance arteries
(mean control diameter 500 p.m). Using an in situ perfused mesenteric arterial tree, and
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controlling mesenteric blood flows between 0.2 and 4.0 ml/min, intraluminal mesenteric
pressure was found to increase linearly with flow in both normal and hypertensive rats,
with absolute pressures for the hypertensive animals significantly higher. There was a mild
trend for an increased diameter with flow in both normal (5%) and hypertensive (4%) rats,
although no difference existed between the two populations. Removal o f the luminal
endothelium by CO2 gas infusion resulted in increased arterial resistance in both rat strains,
with a decreased lumen diameter only in the normal rats. Administration o f L-NAME to
inhibit NO synthesis did not alter mesenteric pressure in either strain.

L-NAME

significantly decreased conductance arterial diameter during flows o f 0.2 and 2.0 ml/min in
normal rats while not having any effect on diameters in the hypertensive rats. Results
from this in situ model using both normotensive and hypertensive rats suggests that
luminal endothelium plays similar roles in the control o f mesenteric arterial resistance in
both strains, and that conductance arteries from normal rats exhibit significant flowdiameter dependency which is adversely altered by both endothelium removal and NOS
inhibition.

In contrast, in hypertensive rats the diameter-flow relationship was not

susceptible to alterations induced by L-NAME or by removal of the endothelium. In both
strains, a positive interaction was discovered between flow-induced vessel dilation and
increases in mesenteric transmural pressure.
Through establishment of a unique unilateral orchidectomy model in developing
rats whereby blood flow was decreased subsequent to a decreased demand, Wang and
Prewitt (187) analyzed microvascular cremaster arterioles during normal development and
in the presence of reduced blood flow. Three weeks after performing the orchidectomy.
and using arterioles of the intact contralateral cremaster muscle for controls, total
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ipsilateral blood flow was reduced approximately 44%, yet flow per gram of tissue
remained stable. The reduced flow yielded inhibition o f normal vascular development as
evidenced by the following: the lumen diameters of feeding (1A), arcading (2A),
precapillary (3 A), and transverse (4A) arterioles; the number of 4As per 3A and the
cross-sectional wall areas o f 1A 2A and 3A arterioles, were all diminished when
compared to controls. The authors speculated that the decreased blood flow resulted in a
diminished shear stress, which alone or in combination with an altered production of
metabolic growth factors, mediated the flow-dependent arteriolar growth retardation. In
addition, a significant correlation was found between cross-sectional wall area and relaxed
(10'3 M adenosine) internal diameters for all 4 orders of cremaster arterioles. In summary,
results from these studies have substantiated the role of intimal ECs in sensing fluid shear
stress and in mediating responses of the adjacent medial smooth muscle layer in both large
and small vessels.
Mechanisms of Flow-mediated Vascular Remodeling
Considering the location of the endothelium and its vital role as a biomechanically
responsive interface between flow-mediated shear stress and the medial wall, most
experiments performed on shear stress have utilized cultured ECs from a variety of
sources.

These experiments generally use a cone-plate viscometer, a parallel-plate

viscometer, or a capillary tube viscometer to expose the grown endothelial monolayer to
controlled shear stresses (109, 148). The cone-plate viscometer has the advantage of not
exposing ECs to a hydrostatic pressure component (in addition to shear stress). When the
endothelium is exposed to increased shear stress, diverse responses occur ranging from
immediate changes (msec) to prolonged chronic changes (hours to days). Rapid responses
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include primarily biochemical and electrophysiological events such as changes in ionic
conductance, inositol triphosphate generation, adenylate cyclase activity, activation of
guanosine 3’,5’-cyclic monophosphate (cGMP), elevation o f intracellular free calcium,
release o f neurotransmitters including substance P, ATP, and acetylcholine, and the release
of significant amounts o f NO and prostacyclin necessary for smooth muscle-dependent
dilation (12, 35, 37, 165). Evidence indicates these early responses to flow act primarily
to initiate second messenger cascades, induce vasotonic adjustments, and start EC
deformation as an auto-regulatory mechanism to decrease the amount o f shear stress to
which the endothelium is exposed (148, 166).

Secondary intermediate responses are

primarily biological growth responses associated with transcription factor activation,
regulation of gene transcription, protein synthesis, and changes in cell cycle kinetics.
Initiation of gene transcription for factors such as c-fos, c-jun, endothelin-1, nuclear factor
kappa B, eNOS, tissue plasminogen activator, TGF-pl, monocyte chemotactic protein,
bFGF, and PDGF all occur within minutes to several hours after onset o f the stimulus (35,
148, 165).

These secondary responses can also include stimulation of pinocytosis,

initiation of cytoskeletal reorganization, focal adhesion rearrangement, and diverse cellwide adaptive responses. Delayed responses represent chronic cellular adaptations to new
hemodynamic conditions and include permanent cytoskeletal reorganization and cell
alignment, organelle redistribution, normalization of mRNA levels, increased mechanical
stiffness, and extracellular matrix restructuring with changes in thrombomodulin, collagen,
and fibronectin synthesis (35, 37, 148).
Endothelial mechanotransduction of a shear stress stimulus generally operates via
one of two mechanisms, or most likely through a combination o f both, and involves many
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of the factors cited above.

The first pathway involves shear stress-generated force

transmission through cytoskeletal components acting to distribute the sensed stimulus to
the nucleus, to neighboring ECs, or to abluminal focal adhesion sites of attachment on the
substratum. Luminal transmembrane proteins are stimulated by shear stress leading to
conformational changes in vimentin-rich intermediate filaments and F-actin stress fibers
(35). On the abluminal focal sites, conformational changes in these microfilaments can
activate, through various linker proteins (talin, vinculin, paxillin, a-actinin), membrane
integrins associated with both the intracellular and extracellular environments. This could
lead to rapid transmission of the stimulus through the substratum to the medial SMC layer
and subsequent responses (37). The second pathway involves force signal transduction
through the EC involving luminal membrane signaling and second messenger stimulation.
This, in turn, initiates a biochemical signaling cascade leading to nuclear gene regulation
and adaptive responses. The membrane signaling step entails sensing the shear stress
stimulus through a shear stress-sensitive ion channel, possibly a non-specific stretchactivated antiport channel allowing sodium and calcium entry with potassium removal
from the EC (93), or a shear-dependent opening of a potassium channel leading to
hyperpolarization of the cell coincident with calcium entry (128, 131).

This initial

response can initiate a biochemical cascade involving phosphatidylinositol metabolism,
cyclic GMP, protein kinase C, and activation o f nuclear transcription factors such as
nuclear factor kappa B, activator protein-1, and a shear stress-sensitive response element
(34, 37). These, in turn, may regulate gene activation for such factors as PDGF, TGF-P1,
immediate early genes (c-fos, c-jun, egr-1), tissue plasminogen activator, endothelin-l,
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monocyte chemotactic protein-1, vascular cell adhesion molecule-1, intracellular adhesion
molecule-l, and NOS (34, 35, 37).
In addition to these experiments aimed at analyzing the influence of shear stress on
ECs, several investigators have recently discovered that medial SMCs in intact blood
vessels can directly experience shear stress (3, 4, 188). These authors have shown that
SMCs can be exposed to shear stresses up to 10 dyn/cmz as a result of interstitial fluid
flow driven by the transmural pressure gradient across the medial wall. The impact of
shear stress on medial SMCs may stimulate similar biochemical factors as those cited
above for the endothelium; however, further work needs to be done in examining the
direct impact o f shear stress on SMCs.
Through a derivation in the LaPlace relation, vasoactive flow-mediated luminal
expansion can increase circumferential wall stress. Experiments analyzing the impact of
wall stress on vessel remodeling have been performed on ECs and SMCs from a variety of
experimental preparations (reviewed in 165). Both ECs and SMCs exposed to wall stress
experience similar responses compared to those discussed above for shear stress. These
include ion channel activation, protein phosphorylation, second messenger signaling, gene
activation, growth factor induction, and cellular structural remodeling (165).

Several

recent reviews offer thorough comparisons o f these and other mechanical stresses and
their roles in vessel remodeling (46, 121, 165).
Endothelial Nitric Oxide Synthase
Nitric oxide is an endothelium- and smooth muscle-derived vasoactive factor that
was originally identified by Furchgott and Zawadzki in 1980 (49).

Based on their
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experiments using rat isolated aortic rings, results suggested acetylcholine stimulated ECs
to release an “endothelium-derived relaxing factor” that induced vessel relaxation. This
mediator was later identified as nitric oxide by Furchgott and others (47, 69). Nitric oxide
contributes to the regulation o f local and systemic vascular resistance, distribution of
blood flow and oxygen delivery, electrolyte balance, and regulation of arterial pressure
(178).
Nitric oxide is synthesized by vascular ECs and SMCs from one of the two
terminal guanidino nitrogens o f L-arginine following its conversion to L-citrulline by a
nitric oxide synthase enzyme complex. Three isoforms of NOS have been identified which
share <59% homology in terms o f human amino acid sequences (43). Isoform I of NOS
has been referred to as bNOS (brain) or cNOS (constitutive and/or Ca2+-regulated), but is
commonly termed nNOS (neuronal). Isoform I is constitutively expressed in neuronal and
certain epithelial cells and is regulated by Ca2+ and calmodulin.

Isoform I functions

indirectly to regulate synaptic transmission o f the CNS, mean arterial blood pressure, and
smooth muscle relaxation and vasodilitation via peripheral nitrergic nerves (43). Isoform
H is not constitutive but can be induced by various cytokines and bacterial
lipopolysaccharide in a variety o f cells. This isozyme is thus referred to as inducible NOS
(also known as macNOS for the macrophage cell type). Isoform II is not dependent on
Ca2+-calmodulin. This isozyme acts to inhibit iron-containing enzymes and is involved in
DNA fragmentation and in the pathophysiology of autoimmune diseases and septic shock
(43). Both isoforms I and II are predominantly soluble enzymes, and both use molecular
oxygen, NADPH as a cosubstrate, and FAD, FMN, and 6(R)-5,6,7,8-tetrahydrobiopterin
as cofactors (178).
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Isoform QI of NOS normally accounts for both constitutive basal and stimulated
NO synthesis in ECs throughout the vasculature (24, 43). This isozyme is more than 90%
particulate (45); however, eNOS can be phosphorylated in response to certain agonists
which induce translocation o f the enzyme from the membrane-bound particulate fraction
to the cytosolic subcellular fraction (116).

Post-translational modifications of eNOS

include palmitoylation and myristylation which, along with Ca2+-calmodulin and
intracellular pH, aid in its regulation. The addition of palmitic acid to eNOS has been
shown to cause localization o f the enzyme to endothelial caveolae (50), and
depalmitoylation of eNOS was found to induce cytosolic translocation and subsequent
phosphorylation (151).

Sessa et al. (164) recently reported that eNOS is a Golgi-

associated protein in cultured aortic and vein ECs and in intact vessels, and this membrane
association is necessary for efficient synthesis o f NO. Venema et al. (183), however,
suggested that membrane association o f eNOS functions to inhibit its catalytic activity by
interfering with its calmodulin-binding domain. Isoform III o f NOS uses heme, molecular
oxygen, NADPH, FAD, FMN, and tetrahydrobiopterin as cofactors (178).

Normal

homeostatic conditions of the EC allow for basal levels of NO production through eNOS
which continually regulates vascular resistance and maintains arterial tone. This occurs
through stimulation of soluble guanylyl cyclase and modulation of cGMP in vascular
SMCs (44, 70). Basal levels o f NO produced from eNOS, as well as NO release through
nitrergic nerves, serve to counterbalance the vasoconstriction normally produced by the
renin-angiotensin system and the sympathetic nervous system. Basal release of endothelial
NO also serves to maintain a nonthrombogenic vascular environment by inhibiting platelet
aggregation and platelet and leukocyte adhesion to the vessel wall (5, 140, 141). Nitric
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oxide has been found to stimulate DNA synthesis in microvascular ECs (198) as well as
directly mediate angiogenesis and EC growth and migration (97, 199).

In contrast,

eNOS-mediated NO production has been shown by several investigators to inhibit DNA
synthesis, mitogenesis, and proliferation of vascular SMCs (SI, 52, 122). A negative
feedback mechanism has been suggested for NO synthesis, as the addition o f NO and NO
donors non-competitively inhibit eNOS activity and endothelial NO production in
response to receptor-dependent agonists and increased flow (8). Considering the role of
hemodynamic stresses in regulating eNOS, the 5’-promoter region of eNOS contains a
putative acute-phase shear stress response element similar to the SSRE found in PDGF
and other shear stress-responsive genes (110).
Flow-induced increases in NO transcription and stimulation of NO production and
release have been substantiated by numerous investigators using in vitro, in vivo, and
isolated intact vessel preparations (27, 28, 62, 78, 87, 88, 103, 127, 130, 169); however,
the regulation o f eNOS by shear stress has only recently been investigated. This NOdependent vasoactive relaxation in response to elevated blood flow acts as a feedback
mechanism to restore wall shear stress towards normal homeostatic levels. Alternatively,
any decrease in vessel diameter at constant flow would increase local shear stress, with
subsequent

endothelial

NO-mediated

vessel

relaxation

offsetting

the

original

vasoconstriction (24).
Nishida et al. (126), in an initial attempt to characterize eNOS mRNA and protein
expression, exposed BAECs to 15 dyn/cm2 for 24 hours using a parallel plate viscometer.
Northern and Western analyses revealed significant increases in eNOS mRNA transcript
levels and eNOS protein expression in cells exposed to increased shear stress compared to
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static controls. These increases in eNOS activity then, through production and release of
NO, could have direct influence on shear stress-mediated endothelium-dependent vascular
relaxation. A subsequent study by the same laboratory (177) attempted to characterize the
mechanisms, time course, and dose response characteristics o f these shear stress-induced
increases in eNOS. In this study by Uematsu et al. (177), BAECs and HUVECs were
grown on a parallel plate viscometer and exposed to shear stresses varying between 1.2
and 15 dyn/cm2 for I to 24 hours.

A 3 hour exposure to 15 dyn/cm2 yielded an

approximate 270% increase in eNOS mRNA versus static controls and directly increased
eNOS mRNA levels in a dose-dependent manner. Results from administration o f gene
transcription inhibitors, potassium channel antagonists, and PK-C inhibitors suggested that
shear stress-induced eNOS expression is dependent on de novo gene transcription, is
regulated by potassium channel opening, and may not require PK-C activation.

In

addition, analysis o f endothelial cell nitrite production indicated an increased capacity of
the ECs to release NO upon exposure to shear stress.
Ranjan et al. (142) attempted to characterize the influence o f shear stress on eNOS
expression in BAECs and HUVECs. Using a parallel plate viscometer, eNOS peptide
expression was elevated after a 3 hour exposure to 25 dyn/cm2. This increase remained
through 12 hours o f flow exposure. Shear stress exposure to 4 dyn/cm2 did not elicit any
significant increase in eNOS protein levels in either cell type. Endothelial NOS mRNA
levels were found to be elevated 2- to 3-fold after 6 and 12 hours’ exposure to both 4 and
25 dyn/cm2. Using dexamethasone to suppress the inducible function of eNOS, results
indicated that all shear stress-mediated responses were specific for constitutive activation
of eNOS. Results from various pharmacologic interventions suggested that flow-induced
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NO was not involved in a positive feedback mechanism to cause an increase in eNOS, nor
was PK-C activation necessary for the shear stress-mediated responses evidenced in this
study.
The influence of cyclic strain on eNOS activity has recently been studied by
Awolesi et al. (9, 10) using cultured BAECs. Endothelial cells subjected to deformation at
60 cycles/min with 6 and 10% strain exhibited upregulation of both eNOS transcripts and
protein levels after 24 hours (9). In order to examine whether this upregulation was
translated into functional activity, this same group analyzed ECs exposed to 10 and 24%
strain for 24 hours (10). Nitric oxide production was indirectly assessed by measurement
of L-citruIline accumulation and by measuring total nitrite in the media (according to the
Greiss reaction). Results demonstrated that cyclic strain increases NO production through
stimulated eNOS activity in cultured BAECs.
Recently, an interesting study was published considering the influence of NO on
bFGF in inducing growth of aortic SMCs. Hassid et al. (61) exposed primary cultures of
rat aortic SMCs to several agents capable o f activating the cGMP pathway. These agents
were found to stimulate bFGF-induced [3H]-thymidine incorporation by several-fold.
These authors suggested that endogenous NO may act to amplify the mitogenic actions of
bFGF in vivo. In addition, Morbidelli et al. (120) demonstrated that the mitogenic actions
of VEGF on cultured coronary microvascular venular ECs are directly mediated by the
presence of NO donors and inhibited by NOS antagonists. These results are supported by
several investigators who found NO to be directly involved in cell replication and
angiogenesis (97, 198, 199), but incompatible with the results indicating that NO alone
inhibits growth and proliferation of aortic SMCs in culture (51, 52, 79, 122). Other
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vasodilators, including ANF and calcium channel antagonists, also inhibit mitogenesis and
proliferation of cultured vascular SMCs (2, 25).
Platelet-derived Growth Factor
Platelet-derived growth factor is a 28 - 35 kD dimeric peptide secreted from
SMCs, ECs, macrophages, and fibroblasts (155). PDGF exists as a disulfide-linked homo(-AA or -BB) or hetero-dimer (-AB) which binds to specific high-affinity cell surface
receptors on mesenchymal cells such as SMCs, ECs, fibroblasts, osteoblasts, and
astrocytes (123, 16, 31).

The PDGF receptors are composed o f two complimentary

subunits, a - and p-, which bind in the presence of a PDGF dimer to form three distinct
receptors: a a , aP, and pp. Ligand specificity of the receptors dictates that PDGF-AA
binds only to a a receptors, PDGF-AB binds to a a or aP receptors, and PDGF-BB binds
to aP or PP receptors (123). Upon ligand-receptor binding, all three forms of PDGF can
bind heparin, stimulate vasoconstriction and SMC mitogenesis, and enhance chemotaxis in
SMCs, monocytes, and neutrophils (153, 155).

Much research has focused on

characterizing these mitogenic and chemotaxic properties of PDGF in various cell types
under normal and stimulated conditions.
Under normal in vivo conditions, medial SMCs constitutively express low levels of
PDGF-A mRNA (18), translated PDGF-AA protein (reviewed in 123), and PDGF-a and P receptors (113).

PDGF-A, however, can also be expressed in microvascuiar

endothelium (18). In comparison, under both normal in vivo conditions (18) as well as
during atherogenesis (192) PDGF-B transcripts are localized primarily to the endothelium
with lower levels found in the media (104). Several laboratories found cultured arterial
SMCs capable of transcribing PDGF message in addition to the -A form (125, 163, 185).
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Majesky et al. (104) found both PDGF-A and -B mRNA transcripts expressed in small
amounts in normal newborn and adult rat aortic SMCs under in vivo conditions. In cell
culture, PDGF-B transcripts accumulated in the SMCs of young rats with no PDGF-B
expression observed in adult rat SMCs. Equal levels o f PDGF-A mRNA were found in
cultured SMCs in newborn and adult rats.

These results suggested a differential

expression of PDGF-B exists and may be related to the age of the animals. Barrett et al.
(IS) found a 3.7 kilobase RNA homologous to the sis (PDGF) gene expressed at
extremely low levels in BAECs m vivo, at minimal levels in HUVECs in vivo, and at
moderate levels in cultured human and bovine ECs. This implies that the PDGF gene may
become activated under m vitro conditions, and the authors suggested that PDGF may be
involved in vascular development of young animals and in maintenance o f a homeostatic
vascular system in adult animals.
The influence of physiologic stresses on PDGF transcription and protein
translation has been performed on ECs and SMCs in vivo and in cell culture using models
o f hypertension (123), atherosclerosis (72), mechanical strain (193) and injury (30), flow
reduction (85, 107) and flow elevation (64, 65,66, 172). The remainder of this discussion
focuses specifically on the effects of blood flow and its associated stresses on PDGF
expression. Hsieh et al. (66), in 1991, investigated the effects of shear stress on PDGF-A
and PDGF-B mRNA expression in primary HUVEC cultures. Under control conditions,
the level of PDGF-A mRNA was negligible while a baseline level of PDGF-B mRNA
expression was detected. Using a parallel plate flow viscometer and a physiologic level of
shear stress (16 dyn/cm2), transient increases in PDGF-A (> 10-fold) and PDGF-B (2- to
3-fold) mRNA occurred after approximately 1.5 hours and returned to baseline levels after
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approximately 4 hours. Shear stress “dose-dependency” was analyzed using exposure
levels from 0 to 51 dyn/cm2 for 2 hours. Results showed a shear stress-dependent increase
in both PDGF-A and PDGF-B mRNA between 0 and 6 dyn/cm2, with PDGF-A mRNA
levels remaining elevated but steady between 6 and 51 dyn/cm2. PDGF-B mRNA levels
subsequently declined between 6 and 31 dyn/cm2, then increased between 31 and 51
dyn/cm2. These results showed PDGF-A and -B expression can be enhanced through
increased shear stress in HUVECs m vitro. In addition, these authors found that shear
stress-induced PDGF-A exists as two major transcripts (-2.5 and 3.0 kb) and two minor
transcripts (~1.7 and 3.8 kb), while shear stress-induced PDGF-B exists as a single
transcript (-3.7 kb).
In 1992, Hsieh et al. (65) investigated the signaling mechanisms behind shear
stress-induced PDGF expression in HUVECs.

Using a similar protocol as in the

experiment described above (66), and with the use of various pharmacologic agents,
results suggested that shear stress-induced PDGF-A and -B mRNA expression is mediated
by a calcium/phosphoinositide-dependent diacyl glycerol-activation o f PK-C in which
heterotrimeric G-proteins may also play a role. Basal levels of PDGF (primarily -B)
expression were also determined to be PK-C-dependent.

Protein kinase C, then, was

hypothesized to activate nuclear gene transcription for PDGF. Prostaglandin synthesis,
extracellular calcium, and cyclic AMP- and cyclic GMP-dependent protein kinases,
however, were not involved in the shear stress-induced responses. In a subsequent study
by the same authors (64), HUVECs were exposed to a physiologic level of shear stress
(-16 dyn/cm2) in pulsatile (1 Hz) and steady flows on a parallel plate viscometer.
Although PDGF-A mRNA levels were low in stationary cells, expression increased (>10-
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fold) after 1.5 hours under both steady and pulsatile flows. PDGF-B mRNA levels were
more abundant in stationary cells, and expression was also increased (<2-fbld) after 1.5
hours under steady and pulsatile flows. Generally, steady flows elicited greater responses
than pulsatile flows for both PDGF-A and -B transcripts.

In this same study,

hypothesizing that similar shear stress-induction mechanisms may exist for c-fos and
PDGF, c-fos antisense technology was used to determine if c-fos regulates shear-induced
PDGF induction.

The antisense treatment completely abolished c-fos transcription

without affecting PDGF mRNA induction, suggesting that flow-induced c-fos expression
may not mediate flow-induced PDGF expression.
Further studies continued to elucidate the mechanisms of shear stress-induced
PDGF expression. Mitsumata et al. (118) exposed BAECs to 30 dyn/cm2 for periods up
to 24 hours in a parallel plate viscometer in an attempt to examine the influence of PK-C
in PDGF expression. PDGF-B mRNA expression was increased after 3 hours of exposure
to shear stress, and significantly elevated 13-fold after 6 hours’ exposure.

PDGF-B

mRNA levels remained significantly elevated for the duration of the experiment; however,
control PDGF-A levels were quite low, and no significant changes in PDGF-A expression
were observed at any time point during the experiment.

Through the use of various

pharmacologic agents that activate or inhibit PK-C, results suggested that both PK-Cdependent and PK-C-independent pathways exist that are capable of inducing PDGF-B
mRNA expression in BAECs exposed to shear stress. In addition, these authors found an
interesting result pertinent to the present study. Treatment of the ECs with TGF-fl (0.1 10 ng/ml) stimulated PDGF-B mRNA expression without affecting PK-C levels.

In

addition, in contrast to the results from Hsieh et al. (64) where c-fos mRNA expression
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was significantly elevated after 30 minutes’ exposure to shear, in this study 30 dyn/cm2 did
not alter c-fos expression at any time point.
Resnick et al. (147) used a cone-plate flow viscometer to expose BAECs to 10
dyn/cm2 for 4 hours, and elicited a significant increase in PDGF-B mRNA. The promoter
region o f the human PDGF-B chain gene was found to contain the necessary elements for
flow-responsiveness through use of a transfected reporter gene. Using a series of mutant
human PDGF-B promoter (1.3 kb)-chloramphenicol acetyltransferase (CAT) reporter
gene constructs transfected into ECs, these authors discovered a c/s-acting component in
the PDGF-B promoter region that is necessary for shear stress-responsiveness. This shear
stress response element contains a six base pair core-binding sequence that binds to shear
stress-induced transcription factors leading to gene expression. This transcription factor
binding site (or its compliment) has been found in the promoters of other shear stressinduced factors such as endothelin-1 (108), tissue plasminogen activator, the nuclear
protooncogenes c-fos and c-jun, monocyte chemotactic protein, and intracellular adhesion
molecule I (reported in 147). Halnon et al. (60) exposed BAECs to shear stress (10
dyn/cm2) in an effort to analyze the mechanism o f PDGF-A mRNA induction.

Shear

stress elicited a several-fold increase in PDGF-A mRNA after 2 hours. CAT-reporter
gene constructs transfected into ECs caused a two-fold increase in activity with exposure
to shear stress, suggesting that shear stress-induced upregulation of PDGF-A mRNA is
due in part to transcriptional activation. A SSRE specific for PDGF-A is thought to exist
independent of the SSRE identified for PDGF-B, but this element has yet to be defined.
Considering the mechanisms of PDGF induction, Miano et al. (I IS) used a balloon
injury model in rat aorta and found increased SMC c-myc and thrombospondin after 2
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hours. This was followed by increased mRNA expression for PDGF-A TGF-01, and a
bFGF receptor. Seven days after initiation o f the injury, a spontaneous increase in c-myc
and thrombospondin mRNA was detected again, followed 12 hours later by a significant
increase in SMC DNA replication. These authors suggested that an autocrine mode of
growth factor-stimulated SMC proliferation exists in vivo, and that immediate early genes
act to regulate this process. This corroborates the findings of Reidy and coworkers (185)
who demonstrated PDGF-induced SMC proliferation after arterial injury occurs in vivo
through autocrine action affecting primarily intimal-associated SMC.

In addition,

Khachigian et al. (81) determined that egr-1, a serum-inducible phosphoprotein that acts
as an “early growth response gene”, is stimulated through mechanical injury to displace
the Sp-l site on the PDGF-B promoter.

This, in turn, upregulates PDGF-B in ECs

exposed to mechanical vascular injury.
In contrast to the results discussed above concerning PDGF induction from
exposure to shear stress, Malek et al. (107), using a cone-plate viscometer and cultured
BAECs, found PDGF-B mRNA expression to decrease significantly 3.9-fold and 4.2-fold
after 9 hours’ exposure to steady laminar shear stress at levels of 15 and 36 dyn/cm2,
respectively. This decrease, however, was preceded by a transient nonsignificant increase
in PDGF-B mRNA at 30 minutes, followed by a return to control levels by I hour with
subsequent decreases through 9 hours. PDGF-A mRNA expression was not detected in
this cell line, consistent with the findings o f Mitsumata et al. (118), yet contradictory to
the results from Collins et al. (26) and Halnon et al. (60) on shear stress-induced ECs. No
differences were observed between responses to steady and pulsatile flows (average -15
dyn/cm2) or between laminar and turbulent flows, in terms of PDGF-B inhibition. These
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authors suggested that the magnitude o f shear stress is more important in growth factor
regulation than the dynamic characteristics o f the shear stress stimulus.

In addition,

temporal variation in the shear stress-regulation of PDGF mRNA expression may be
evident considering the general trend for early PDGF induction (64, 65, 66, 147) followed
by inhibition of PDGF mRNA expression (107). In a separate study by Kraiss et al. (85)
using flow alterations in baboon aortoiliac prosthetic grafts, PDGF-A mRNA levels were
significantly elevated in low-flow grafts compared to high flow grafts. Results from ICC
and ISH indicated the increased PDGF-A protein and transcript levels were localized to
the luminal endothelium and subjacent SMC layer. These authors proposed that abrupt
reductions in blood flow induce accelerated neointimal thickening which may be
temporally and anatomically regulated by PDGF-A

Similar results were found by

Majesky et al. (106), who used a carotid balloon injury model and discovered both
immediate and chronic elevation o f PDGF-A transcripts and protein levels located
preferentially on the neointimal SMCs.
Interactions between PDGF and other vasoactive peptides and growth factors have
been studied using a variety o f experimental protocols in various cell types. Stavri et al.
(170) studied the roles of hypoxia and PDGF-B in inducing VEGF transcription in
cultured rabbit aortic SMCs. Hypoxia alone strongly upregulated VEGF mRNA in a timeand concentration-dependent manner, reaching a maximum 30-fold increase after 1 2 - 2 4
hours. Exposure to PDGF-B caused only minimal increases in VEGF expression. The
combination of hypoxia and PDGF-B administration, however, caused a synergistic
increase in VEGF mRNA that was ~2-fold higher than the expected additive effect. These
authors suggested that VEGF-mediated neovascularization may be mediated in part
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through the synergistic interaction observed between hypoxia and PDGF-B in cultured
SMCs. Bilato et al. (17) examined the interaction between bFGF and PDGF in mediating
rat aortic SMC migration in cell culture. Basic FGF was weakly chemoattractant for
SMCs but was required for PDGF-stimulated SMC migration.

Further analysis

demonstrated that bFGF exerted this effect through enhancing PDGF-mediated release o f
intracellular calcium and the subsequent activation of calcium-calmodulin-dependent
protein kinase II. PDGF-B has also been suggested to upregulate FGF tyrosine kinase
receptor mRNA and protein (90). Thommes et al. (174) found PDGF-A and IGF-1 to be
weakly mitogenic for cultured rat aortic SMCs; however, co-administration of these
factors resulted in significantly increased [3H]-thymidine incorporation and a strong
increase in SMC number. These authors proposed that the synergistic actions of PDGF-A
and IGF-1 might be due to differential activation of their intracellular signaling pathways.
PDGF from extracts o f human platelets has also been shown to rely on the presence of
TGF-P 1 and EGF in stimulating anchorage-independent transformation o f neoplastic rat
kidney fibroblasts (7). This oncogenic growth was found to depend on the presence o f all
3 growth factors. Bonner et al. (19) determined that TGF-PI causes downregulation of
PDGF alpha receptors in fibroblasts during pulmonary fibrotic disease. These authors
suggested that the proliferative and chemotactic influences o f PDGF are dependent on the
modulation of its receptor subtypes by other injury-induced cytokines such as TGF-P 1.
Fibroblast Growth Factor
Basic fibroblast growth factor (bFGF) is a potent heparin-binding polypeptide
mitogenic for vascular ECs and SMCs. Arterial and capillary ECs, SMCs, and fibroblasts
can synthesize both aFGF and bFGF (18), while bFGF can also be produced in a wide
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variety of tissues including brain, pituitary, retina, adrenal gland, kidney, corpus luteum,
placenta, and in various tumors (162).

Basic FGF has important chemotactic and

angiogenic properties as well as vital roles in development of the vascular, nervous, and
skeletal systems and in cellular differentiation (90). Lindner and co-workers found SMC
proliferation in lesions resulting from endothelial denudation in rat carotid arteries to be
bFGF-dependent (101, 102). Basic FGF has been shown to play a role in autocrine
growth regulation for capillary ECs (162) and in autocrine migration of cultured ECs
(117).

Sakaguchi et al. (156) determined that bFGF acts in an autocrine fashion by

binding to cell surface receptors from the cells where the factor was originally produced.
Basal levels of transcription for both aFGF and bFGF are low; however, both proteins
appear at relatively high levels in many tissues (124). This may be dependent on the fact
that bFGF does not contain a signal sequence; therefore, release of bFGF peptides occurs
through conjugation with carrier proteins (18), sequestration by ECM constituents (11),
or through cell lysis in vascular injury (30). Newly synthesized bFGF can be secreted and
become associated with the basement membrane and extracellular matrix components such
as heparan sulfate (149).

Saksela et al. (158) suggested that FGF conjugation with

extracellular glycosaminoglycan heparan sulfate protects FGF from proteolytic
degradation.

In agreement, Baird and Ling (11) in their work on cultured BAECs,

hypothesized that the neovascular response stimulated by bFGF is more regulated by the
presence of heparinase-like enzymes than by the actual angiogenic or mitogenic activity of
the growth factor. However, differential responses were observed by Yu et al. (196) in
their work on cultured BAECs. These investigators discovered that cells cultured to
subconfluency synthesized bFGF which became localized to the nucleus and exocytotic
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vesicles, while confluent cells produced bFGF which became predominantly ECMassociated.

Four distinct high affinity FGF receptors exist that exert tyrosine kinase

activity and dimerize upon ligand-binding (124). FGF receptors have been identified on
ECs, SMCs, myoblasts, and fibroblasts (18). Generally, most of these receptors have
increased affinity for the basic form over that for the acidic form. For a thorough review
of FGF receptors, please consult the articles by Schott and Morrow (161) or Bobik and
Campbell (18).
Considering the angiogenic and growth-regulatory characteristics of bFGF and its
role in mediating responses due to injury or in atherogenesis, bFGF has been proposed to
play a role in the pathogenesis of shear stress-induced alterations. Sterpetti et al. (172)
examined arterial SMCs exposed to varying degrees of shear stress, and found a “dosedependent” release of bFGF into the medium that was still evident 24 hours after
cessation of flow. Anti-bFGF antibody treatment verified the specificity of the mitogen,
and results suggested shear stress stimulates SMCs to produce and release bFGF in direct
proportion to the degree of flow in an in vitro system. Malek et al. (107) explored the
effects of shear stress on induction of bFGF mRNA in BAECs cultured on a cone-plate
viscometer.

Steady laminar shear stress o f 15 dyn/cm2 elicited a significant 1.5-fold

increase in bFGF mRNA between 30 minutes and 6 hours, declining to baseline levels after
9 hours. Steady laminar shear stress of 36 dyn/cm2 caused a significant increase at 30
minutes, reached a 5-fold increase at 6 hours, and remained elevated 3-fold after 9 hours’
exposure.

This elevated level of shear stress induced three bFGF mRNA species of

approximate sizes 7.0, 4.0, and 1.9 kb. No differences were observed in bFGF mRNA
expression between steady laminar and turbulent flows, or between steady laminar and
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pulsatile laminar flows. These results suggest that the dynamic characteristics of the fluid
flow do not play as important a role as the overall magnitude of the shear stress in terms
of stimulating bFGF gene expression.
Transforming Growth Factor
Transforming growth factor-p I (TGF-pi) is a pleiotropic factor that has been
shown to stimulate vascular SMC hypertrophy, inhibit mitogen-stimulated DNA synthesis,
and has been suggested to be a mediator of SMC growth in vivo during atherogenesis and
wound repair (6, 29, 105, 135). After synthesis, TGF-pi is normally secreted from ECs,
SMCs, and fibroblasts in a latent inactive form that is unable to bind to its cell surface
mannose-6-phosphate/IGF II receptor (94).

Certain factors such as angiotensin II,

endothelin-l, and TGF-pi itself are capable of activating the latent form and converting it
into a biologically active form, which may then stimulate smooth muscle growth via
hypertrophy or hyperplasia (18, 53).
Considering its bidirectional effects on SMC growth, TGF-pi has been suspected
as playing a role in shear stress-mediated vascular remodeling.

Ohno et al. (131),

exposing cultured BAECs to shear stress on a cone-plate viscometer, found expression of
TGF-PI mRNA to increase directly with increases in shear stress between 0 and 40
dyn/cm2. At constant exposure to 40 dyn/cm2, TGF-pi mRNA levels increased several
fold within 2 hours and remained elevated at 12 hours’ exposure. These authors used a
neutralizing TGF-31 antibody to test for biologically active mature TGF-PI, which was
found to increase significantly in conditioned medium. With use o f channel blockers,
results indicated that the shear stress-induced increases in TGF-P1 mRNA and TGF-P1
protein are mediated through an EC flow-activated potassium channel. In a subsequent
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study (140) these same authors further examined the mechanism o f shear stress-reguiated
TGF-P 1 gene expression. Bovine aortic ECs exposed to 20 dyn/cm2 on a cone-plate
viscometer demonstrated a 3- to 5-fold increase in TGF-P 1 gene transcription after
exposure to shear stress for 2 hours. Using ECs transfected with TGF-P 1 promoter-CAT
reporter gene constructs, results indicated that shear-responsiveness o f TGF-P 1 gene
expression is mediated by shear stress-responsive cis and trans elements activated through
flow-regulated endothelial potassium channels.
In recent work by the same laboratory on shear stress-mediated TGF-P 1 gene
expression and protein secretion (128), cultured BAECs were subjected to varying levels
o f shear stress on a modified cone-plate viscometer. Low levels o f flow (< 5 dyn/cm2)
failed to induced significant alterations in TGF-P 1 mRNA expression; however, between
shear stresses o f 5 and 40 dyn/cm2, TGF-P 1 mRNA levels increased proportionately. In
response to steady laminar shear stress of 20 dyn/cm2, ECs experienced a 3- to 5-fold
increase in TGF-P 1 mRNA levels after 2 hours’ exposure, and produced a 4- to 10-fold
increase in the amount of biologically active TGF-P 1 protein as measured in the
conditioned medium after 24 hours’ exposure to increased flow. Using ECs transfected
with the TGF-P 1 promoter-CAT reporter gene constructs, results indicated that the shear
stress responsiveness of TGF-P 1 mRNA production is dependent on activation of the
promoter region and involves transcriptional regulation. Results from channel blockade
provided further evidence for dependency on a flow-activated endothelial potassium
channel for increased TGF-P 1 mRNA expression. These authors speculated that the
mechanotransduction of a shear stress stimulus through ECs leading to increases in TGF-
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involves regulation between potassium and calcium fluxes, with potassium-induced

hyperpolarization possibly inducing calcium influx and calcium-dependent kinases and
signaling cascades.
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CHAPTER HI
HYPOTHESIS

The general hypothesis for this research project is that elevated flow induces
growth and remodeling of small systemic arteries in the presence o f normal arterial
pressures under in vivo conditions. These arterial adaptations are believed to be mediated
by several endogenous flow-induced biochemical factors. In addition, considering the
model established herein, we expect the primary mechanical stimulus experienced by the
local vasculature to be flow-mediated shear stress with minimal contribution from stretchinduced wall stress.
Specifically, we believe that elevated shear stress will stimulate arterial remodeling
primarily in a radial direction resulting in significant luminal enlargement. We expect this
will involve a combination of cellular hypertrophy and hyperplasia for both the endothelial
and smooth muscle layers between 1 and 7 days.

We expect a restructuring o f the

extracellular connective tissue as well as early involvement o f flow-induced NO (assessed
through eNOS expression). We hypothesize that flow-induced shear stress will stimulate
the expression of several mechanosensitive genes. Principally, we believe that endothelial
PDGF-B mRNA and medial PDGF-A mRNA expression will be elevated and contribute
to enhanced endothelial and SMC proliferation. Secondarily, we believe that shear stress
may act to regulate endothelial and/or smooth muscle bFGF mRNA and endothelial TGFPI mRNA expression. We expect detection of these changes in gene expression within I
day after onset of increased flow and persisting possibly through 3 days.
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CHAPTER IV
RESEARCH DESIGN, MATERIALS, AND METHODS

Rat Mesenteric Flow Model
All experimental protocols in this research project complied strictly with the
guidelines instituted by the Animal Care and Use Training Program, Eastern Virginia
Medical School, Norfolk, VA The Animal Care Facility at EVMS is AAALAC approved
and is directed by Thomas Sheehan, DVM.

Three groups o f ten male Wistar rats

weighing approximately 300 grams each were anesthetized with Na*-pentobarbital (60
mg/kg EM, Anpro Pharmaceutical, Arcadia, CA) and given 0.1 cc penicillin G potassium
(10,000 units IM, Marsam Pharmaceutical, Cheny Hill, NJ). Supplemental IM injections
of Na'-pentobarbital were provided as needed in order to maintain a surgical level of
anesthesia. Once surgical anesthesia was obtained, the abdomens were shaved clean and
swabbed with a topical antiseptic/antimicrobial agent (Hibiclens, Wilmington, DE). The
rats were placed supine on a warm heating pad (~ 37°C) and covered with a sterile
surgical drape so that only the shaved abdominal wall was exposed.

Using sterile

technique, a midline laparotomy was made spanning the length o f the abdomen from
below the diaphragm to above the testis.

The cecum, adjoining section of the small

intestine, and supporting mesenteric membranes and vasculature were gently exteriorized
and placed on the sterile drape. The cecum, intestines and mesentery were kept moist
throughout the entire surgery with pre-warmed, sterile physiological saline (pH 7.4). The
intestines and supporting vasculature were gently arranged in order to examine the fourth,
fifth, and sixth ileal arteries (and veins) proximal to the ileocecal junction for any pre
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existing vascular anomalies. This section of the rat mesenteric vasculature was subjected
to altered blood flow.

In addition, the ninth ileal artery (and vein) proximal to the

ileocecal junction was examined for any abnormalities and acted as the control section for
the rat. If pre-existing vascular anomalies were present in these regions, appropriate
vascular sections were found between the second and eighth ileal arteries proximal to the
ileocecal junction for the treatment group, and between the ninth and the twelfth ileal
arteries for the control group. If no anomalies were found, arterial ligations were made
using sterile 10-0 Ethilon monofilament nylon suture (Ethicon, Inc., Somerville, NJ) on
the following arteries as depicted in Figure 4-1: (1) the parent fifth ileal artery proximal to
the ileocecal junction; (2) the second-order branch of the fourth ileal artery leading in the
direction towards the fifth artery; and (3) the second-order branch of the sixth ileal artery
leading in the direction towards the seventh Deal artery.

In addition, any transverse

marginal artery in the ligated arteriolar arcade that connected two second-order arterial
branches was ligated to form a true barrier to collateral blood flow (4). Deal arteries are
defined as pre-branching first-order parent vessels leading from the superior mesenteric
artery to the ileum, where each divides into two second-order branches. A marginal artery
is defined as a transverse vessel segment joining two adjacent small arterial arcades.
Marginal and second-order arteries give rise to first-order (1 A) arterioles that directly feed
the bowel wall.
Ligations at these specific sites allows various vessels to be subjected to four
different scenarios: (A) high flow, normal pressure in a large ileal artery, (B) high flow,
normal pressure in a smaller second-order artpry; (C) no flow, normal pressure in a smaller
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Rat Mesenteric Flow Model.
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This diagram illustrates the general

mesenteric arterial arrangement with sites of ligation, placement of pressure cannula, and
flow probe used for both acute hemodynamic measurements and chronic morphological
assessments. In the chronic studies, the proximal branch o f the high flow sixth ileal artery
was ligated. Results showed significantly increased blood flow and calculated wall shear
rates in the high flow ileal artery and second-order branch with no significant changes in
mean aortic or mesenteric arterial pressures. This is a paired design model with control
and high flow vessels in the same animal. Control vessels were obtained from the ninth
ileal artery and second-order branch proximal to the ileocecal junction and are not
included in the illustration.
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artery; and (D) low flow, normal pressure in a smaller artery (under the possible influence
of ischemia-induced metabolites). A fifth possible scenario involves first-order arterioles
(l-A) of the intestinal wall located between the fourth and fifth ileal arteries proximal to
the ileocecal junction where ischemia may occur. These sites are illustrated in Figure 4-1.
The focus of this study was on the high flow ileal artery and second-order branch
(denoted on Fig. 4-1 as A and B, respectively) and their matching control vessels. Arterial
ligations were made by first identifying the best site on each vessel branch for the ligation,
and then carefully and gently clearing away surrounding adipose tissue to correctly identify
the artery and adjacent vein. Tremendous care was taken during dissection in order not to
stretch or injure the vessels, and unnecessary manipulation of the vessels was kept to a
minimum. A short piece of suture was cut, gently wrapped around the artery, and tied
twice. Because o f the delicacy of this surgical technique, if the artery was punctured
during the procedure, ligations were made directly above and below the site of damage in
order to ensure cessation of blood loss. Once bleeding stopped, the procedure continued
as normal. Generally speaking, the ligation around the fifth ileal artery was made first,
followed by the ligation around the second-order branch of the fourth artery, and then the
second-order branch o f the sixth artery. During the surgery, the level of consciousness of
the rat as well as the patency of the airway were constantly observed.
Once all ligations were complete, the number of l-A arterioles feeding the
intestinal wall in the flow-dependent region was counted and the length (in mm) of the
flow-dependent region measured. The flow-dependent region is considered to be the
section of bowel receiving blood flow from the feeding sixth ileal artery (corresponding to
section A in Fig. 4-1) proximal to the ileocecal junction. The l-A arterioles counted were
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those that spanned at least 50% of the distance across the radial bowel axis. The cecum,
intestines, and supporting vasculature were then gently placed back into the abdominal
cavity. The muscular abdominal wall was closed and sutured with sterile 4-0 Plain Gut
(Ethicon, Inc.). The abdominal skin was closed using sterile surgical clips, and the area
around the incision swabbed with an antiseptic/microbicidal solution (Pharmadine
Solution, Sherwood Pharmaceutical Co., Mahwah, NJ). The rat was placed in a prone
position on a separate warm heating pad with the upper thorax and head raised to aid
breathing. Ear notches were made for identification. Detailed diagrams o f the individual
vessel arrangement and actual sites of ligation were made immediately after the surgery for
each animal. Once fully recovered from anesthesia, rats were placed into appropriate
cages and returned to the Animal Care Facility. Several hours after each surgery, as well
as the next day after surgery, observations were made on each rat to ensure full recovery.
Animals were provided water and standard rat chow ad libitum for 1, 3, or 7 days.
After the appropriate number o f days, each rat was anesthetized with Na'pentobarbital (60 mg/kg, IM), and supplemental injections of Na*-pentobarbital were
given as needed throughout the remainder of the procedure. Once a surgical level of
anesthesia was reached, MAP was measured through tail artery cannuiation for purposes
of establishing pressure for perfusion-fixation. The ventral portion o f the tail just below
the testis was shaved and cleaned. The animal was placed supine on a warm heating pad,
and a midline incision was made on the proximal ventral portion of the tail to expose the
underlying tissue and sheath covering the tail artery. The surrounding tissue was carefully
dissected away, and the sheath opened to expose the tail artery. Two sutures were placed
under the artery, the distal suture tied twice, and the proximal portion of the artery
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adjacent to the proximal suture clamped with micro-forceps. Lidocaine HC1 (10 mg/ml.
Astra Pharmaceutical Products, Inc., Westborough, MA) was administered topically on
the artery to induce dilation. Using microsurgical Castroviejo scissors, a small incision
was made in the tail artery, and a polyethylene catheter (0.28 mm ID) inserted into the
artery and advanced until it reaches the micro-forceps. Both proximal and distal sutures
were tied around the catheter to secure it. The forceps were released, and a heparin
solution (1000 units/kg BW, Elldns-Sinn, Cherry Hill, NJ) slowly injected into the artery.
The catheter, attached to a calibrated Statham pressure transducer and a Gould Brush
2200 recorder (Cleveland, Ohio), enabled precise and immediate recordings o f tail artery
pressure. The chart speed was set at 5 mm/sec, and a MAP was recorded once stabilized
(approximately 5 minutes).
After a stable pressure was recorded, the rat was gently moved from the heating
pad and placed supine in a collecting pan. A midline laparotomy was made, followed
closely by a pneumothorax as the method for sacrifice.

Since several o f the internal

organs demand large blood flows, ligation of the arteries feeding these organs allowed a
more accurate estimate of pressure during perfusion through the thoracic aorta.

The

abdominal cavity was further opened to allow access to the internal organs. First, the left
renal artery was ligated, followed by ligation of the left and right femoral arteries. The
right renal artery was not ligated as the right kidney served as control for cellular
proliferation. The inferior vena cava below the kidneys was isolated and severed to allow
an outflow for perfiision-fixation. The thoracic aorta above the diaphragm was isolated
and cleared of surrounding tissue. Two long sutures were placed under the thoracic aorta,
and a small cut made in the thoracic aorta using microsurgical Castroviejo scissors. A 14
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G catheter was gently inserted into the vessel, and the catheter secured with the sutures
and attached to a heated dual reservoir setup containing a vasodilator mixture [100 jxM
sodium nitroprusside (Sigma, St. Louis, MO), 100 pM verapamil hydrochloride (Sigma),
100 pM papaverine hydrochloride (Aldrich Chemical Co., Milwaukee, WI), 1 liter 0.9%
physiological saline] and 10% buffered formalin phosphate (Fisher Scientific, Fair Lawn,
NJ). The tubing was cleared of air bubbles, and the vasodilator mixture pumped through
the thoracic aorta catheter and isolated mesentery and right kidney at approximate MAP
(as recorded on the pressure transducer). After approximately 5 minutes, the system was
switched to formalin to allow fixation o f the tissues at approximate MAP. After the
mesentery and right kidney were completely perfose-fixed, the appropriate tissues were
carefully extracted from the rat and placed in 10% buffered formalin phosphate until ready
for microsurgical dissection.

Chart recordings o f MAP and perfusion pressure were

appropriately labeled and saved.
Hemodynamic Parameter Measurements
In a duplicate series of experiments hemodynamic parameters were measured
before and initially after creation of the model by arterial ligation. These measurement
were made by our collaborator, Joseph L. Unthank, Ph.D., in the Department of Surgery,
Indiana University School of Medicine. The left common carotid artery was cannulated in
order to measure MAP.

Following a medial laparotomy and surgical protocol as

described above, a perivascular ultrasonic flow probe (0.5V probe and Model 206
Flowmeter, Transonics Systems Inc., Ithaca, NY) was placed on the sixth ileal artery
proximal to the ileocecal junction (Fig. I). The proximal second-order branch off the
fourth ileal artery proximal to the ileocecal junction was ligated, followed by cannulation
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o f the proximal branch of the sixth ileal artery proximal to the ileocecal junction. The
cannula was oriented away from the flow-dependent region and was inserted for purposes
o f obtaining a local mesenteric arterial pressure. The cannula was constructed from 3 1
gauge MicroFil tubing (World Precision Instruments, Sarasota, FL) sealed in PE 10 and
PE 50 tubing. The fifth ileal artery proximal to the ileocecal junction was then ligated.
The sites of arterial cannulation and ligations are included in Figure 1. Measurements of
blood flow, arterial pressure, and internal diameters of the sixth ileal artery and its distal
second-order branch were made prior to and after each cannulation or ligation as
described above. Ileal artery blood flow measurements were corrected for zero offsets,
and measurements of internal diameters were made through videomicroscopy.

Before

accepting each pressure measurement, the stopcock connecting the cannula to the pressure
transducer was opened to the atmosphere to verify that the cannula was patent as
demonstrated by the entrance of blood into the cannula. Finally, vessels were completely
relaxed through topical administration of a dilator cocktail (10'4 M adenosine, 10's M
sodium nitroprusside), with subsequent measurement of flow, pressure, and diameters.
Wall shear rate was calculated from these data using the formula: WSR = (4Q)/(7tr3)
where Q is blood flow (ml/sec) and r is the vessel radius (cm).
Tissue and Slide Preparation
The right kidney was cleared of surrounding adipose tissue and perirenal fascia,
divided into three cross-sections, and fixed in formalin. The intestines and supporting
mesenteric vasculature were closely examined under the dissection microscope
(StereoZoom 4, Bausch & Lomb). Arteries o f interest and the section of intestinal wall
containing one or more l-A arterioles were carefully extracted and placed in formalin.
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Control vessels and a control section o f the intestinal wall were taken from the appropriate
location and placed in formalin.
All tissues were fixed in formalin for 4 hours, after which each was placed in a
small section o f Kimwipe paper (Kimberly-Clark Corp., Roswell, GA) and labeled.
Keeping the tissues moist throughout this procedure, a maximum of three tissues were
loaded per processing cassette, which was also labeled according to the tissues inside.
The tissues were then placed in the processing unit (Autotechnicon Duo, Technicon
Corp., Tarrytown, NY) for a 1314 hour cycle in the following baths: 70% ethanol, 95%
ethanol, 100% ethanol, xylene, paraffin (Paraplast Plus Tissue Embedding Medium,
Oxford Labware, St. Louis, MO). If a prolonged amount o f time was expected before
tissues were able to be processed, they were placed in the Kimwipe paper, labeled, and
placed in 0.9% physiological buffered saline (PBS), pH 7.4, at 4 °C, until ready for
processing.
After the tissues completed processing, they were transferred to the heating unit of
the tissue embedding center (Tissue Tek II, Lab Tek Products, Division Miles
Laboratories, Inc., Westmont, IL).

The tissues were embedded in liquid paraffin in

molded plastic cassettes, labeled, and allowed to solidify on the cold unit o f the embedding
center. The tissue blocks were stored at room temperature in an ordered fashion until
ready for use.
Tissue sections were cut from paraffin blocks at a thickness o f 4 |om using a rotary
microtome (American Optical 820, Conneaut Lake Scientific, Conneaut Lake, PA). The
tissue sections were placed immediately in 30% RNAse-free ethanol (30% absolute
ethanol, 70% DEPC-H2O). Sections were transferred to a heated tttfeO bath to allow for
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adequate spreading of the tissue. Precieaned Superfrost/Plus microscope slides (Fisher
Scientific, Pittsburgh, PA) were used for all protocols.

For slides used in histologic

staining, vessel sections were placed approximately in the middle of each slide, with only a
single vessel type per slide. For in situ hybridization experiments, control vessels were
placed above same animal treatment vessels on the bottom third o f the slide. Also, for in
situ hybridization experiments, duplicate slides per vessel pair were made for sense and
antisense probes. Slides were labeled appropriately on the frosted end in pencil and stored
in slide boxes at room temperature.
Morphological Analysis
Toluidine blue stain was prepared by adding 1 gram sodium borate and 1 gram
toluidine blue O dye (Eastman Kodak Co., Rochester, NY) to 100 ml dH20 . The was
mixed, filtered, and stored in the dark in a light-proof container. Prepared slides were
deparaffinized in xylene (3 min x 2) and rehydrated in 100% ethanol (10 dips x 3), 95%
ethanol (10 dips), and dH20 (5 min) at room temperature. Slides were placed on a 37 °C
slide warmer (Fisher Scientific) and stained with toluidine blue for 45 seconds. The slides
were rinsed with dH20 , dehydrated in 95% ethanol (10 dips), 100% ethanol (10 dips x 3),
and xylene (3 min x 2) at room temperature. Slides were coverslipped with Accumount
60 mounting medium (Baxter Health Care Corp., McGraw Park, IL).
Microscopic measurement and quantitation of morphological parameters were
performed using JAVA Video Image Analysis Software System (Jandel Scientific, Jandel
Corp.) linked to a Zeiss 25 binocular microscope (Carl Zeiss, Oberkocken, W. Germany).
Pixel gray level thresholds were set for optimum contrast, and inside and outside
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circumferences were automatically traced and digitized. Data transformations provided
values for lumen area, wall area, and inside and outside diameters.
Immunocvtochemistrv Protocols
Proliferating Cell Nuclear Antigen
The protocol used for immunocytochemical localization o f PCNA is modified from
that o f Vector Laboratories (Vector Laboratories, Inc., Burlingame, CA) for use with
paraffin-embedded formalin-fixed tissues. Two slides per sample were used, one positive
and one negative control. Prior to starting the protocol, tissue sections were outlined
using a diamond pencil, and the slides were labeled according to the primary antibody used
(or negative control). Except for the initial incubation step or unless otherwise specified,
all reactions took place at room temperature.
Slides were incubated in a 55 °C oven for I hour or until the paraffin was
completely dissolved. Tissues were deparaffinized and rehydrated in xylene (4 min x 3),
100% ethanol (2 min x 3), 95% ethanol (2 min x 2), 70% ethanol (2 min), and CIH2O (5
min).

Endogenous peroxidase activity was blocked with 0.4% hydrogen peroxide in

methanol for 10 minutes. Slides were washed in PBS for 20 minutes, followed by a 20
minute treatment in a humidified chamber with 5% normal goat serum (Vector
Laboratories) as a blocking agent. The positive slides were treated with the primary
antibody mouse monoclonal anti-PCNA clone PC-10 (Boehringer Mannheim Corp.,
Indianapolis, IN) in a 1:200 dilution with PBS in a humidified chamber for 2 hours.
Negative slides received 5% normal goat serum only, and positive and negative slides
were kept in separate chambers. Slides were then washed with PBS for 20 minutes. All
slides received the secondary antibody biotinylated goat anti-mouse IgG (Vector Labs) in
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a 1:400 dilution with PBS in a humidified chamber for 30 minutes. Slides were washed in
PBS, and treated with Vectastain Elite Avidin-Biotinylated Complex immunoperoxidase
system (Vector Laboratories) for 30 minutes. Slides were rinsed in PBS and incubated in
a diaminobenzidine tetrahydrochloride (DAB, Sigma) chromagen solution for 5 minutes in
a humidified chamber.

The DAB solution contained 0.1 M imidazole, 0.2% DAB,

hydrogen peroxide, and PBS. Slides were washed under running tap water for 5 minutes,
followed by counterstaining with hematoxylin (Gill’s Formulation #1, Fisher Scientific) for
5 minutes. Slides were again washed under running tap water for 5 minutes, dehydrated
and cleared in the following washes: 70% ethanol (2 min), 95% ethanol (2 min x 2), 100%
ethanol (2 min x 2), and xylene (2 min x 2). Slides were air dried and coverslipped with
Accumount 60 Mounting Medium (Baxter Health Care Corp.).

Unless otherwise

specified, all treatments took place at room temperature.
Endothelial Nitric Oxide Svnthase
The ICC protocol for eNOS is similar to that described above for PCNA but with
several exceptions. The endogenous peroxidase blocking step with hydrogen peroxide
was extended to 30 minutes instead o f 10 minutes, followed by a 20 minute wash in PBS.
The tissues were then permeabilized with a 20 minute wash in 0.15% Triton X-100
(Sigma) in PBS, followed again by a 20 minute PBS wash. Blocking serum (5% NGS)
was added as stated above for PCNA. The primary antibody was a mouse affinity-purified
monoclonal IgG-1 against eNOS (Transduction Laboratories, Lexington, KY) used in a
1:1000 dilution. The immunospecificity o f this monoclonal antibody has been validated
through both Western blot and preadsorption immunohistochemistry (195).

Primary

antibody incubation proceeded overnight at 4 °C in a sealed humidified chamber. The next
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day slides were washed briefly with PBS and treated to the secondary antibody
(Biotinylated Goat Anti-Mouse IgG) in a 1:200 dilution for 30 minutes. The procedure
then proceeded as described above.
Analysis o f positive and negative tissues and quantitation of ICC results were
performed through direct microscopic measurement (Zeiss 25 binocular microscope; Carl
Zeiss) and by utilizing the JAVA Video Image Analysis Software System (Jandel
Scientific). For PCNA slides, the total number of medial SMC nuclei, as well as the
number of PCNA-positive and negative SMC nuclei, were systematically counted. For
analysis o f ECs, the absolute number of intimal EC nuclei were counted. These nuclear
counts were subsequently normalized to wall area and luminal perimeter, respectively. For
eNOS analysis, slides were blindly scored according to a 0 - 4 grading scale for positive
stain specific to the endothelial luminal lining. A score of 0 denoted negative staining
while a score of 4 indicated excellent specific stain.
Extracellular Connective Tissue Staining
Tissue cross-sections were stained for extracellular connective tissue using a
modification of the protocol included in Masson’s Trichrome Stain kit (Sigma). Slides
were deparaffinized and rehydrated in xylene (3 min x 2), 100% ethanol (2 min x 2), 95%
ethanol (2 min x 2), 70% ethanol (2 min), and CIH2O (5 min). Tissues were treated with
Bouin’s histological reagent solution (Sigma) for 15 minutes at 56 °C as a general fixative
and to intensify the final coloration step. Slides were washed under running tap H20 for
several minutes and treated with the nuclear stain hematoxylin (Gill’s #1 formulation,
Fisher Scientific) for 5 minutes.

After a short dH20 rinse, slides were treated with

Biebrich-Scarlet acid fuschin solution for 2 minutes to stain muscle fibers and cytoplasm.
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Slides were rinsed in (tffcO and treated with a phosphotungstic-phosphomolybdic acid
solution for 5 minutes, followed by collagen staining in aniline blue solution for 8 minutes.
Coloration was intensified through exposure to a 1% acetic acid solution for 2 minutes,
and the slides were dehydrated and cleared in the following washes: 70% ethanol (2 min),
95% ethanol (2 min x 2), 100% ethanol (2 min x 2), and xylene (2 min x 2). Slides were
air dried and coverslipped with Accumount 60 Mounting Medium (Baxter Health Care
Corp.). Unless otherwise specified, all reagents were included in the kit (Sigma) and all
treatments took place at room temperature. Microscopic evaluation o f these slides was
performed using the video image analysis system Image-1 (Universal Imaging
Corporation, West Chester, PA) linked to a Sony DXC-151 CCD camera (Sony, Japan)
and Nikon Optiphot-2 microscope (Nikon, Japan). Quantitation of percent connective
tissue in vessel medial wall cross-sections was achieved using established stereologic
methods (56). Quantitative stereology provides an efficient and unbiased method for
directly estimating the areal fraction of profiles (in this study the stained connective tissue)
in a standardized area of a structure (the medial wall) through the use o f a fixed test grid
system (56).
cDNA Subcloning
The following is a general description of cDNA subcloning techniques that were
used for preparing linearized DNA used in synthesizing 3SS-CTP labeled riboprobes.
Details are then given concerning subcloning specifications for the following factors:
PDGF-A, PDGF-B, bFGF, and TGF-P 1.
For consistency purposes, and to allow use of standard RNA polymerases T3 and
T7, all cDNAs were subcloned into pBluescript SK+ (Stratagene, La Jolla, CA) if
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originally located in a different plasmid. If in a plasmid other than pSK+, the cDNA was
cut out o f the original plasmid using appropriate restriction endonucleases and buffers, and
the fragment ligated into an appropriate site in pSK+ using DNA ligase.

The DNA

fragment in pSK+ was used to transform XL 1-Blue cells (Stratagene) which were plated
on LB-ampicillin agar plates and grown overnight. Appropriate clones with cDNA inserts
were picked according to the integrity o f the 0 -galactosidase gene and blue/white color
detection.

The cDNA was amplified and purified using Qiagen Plasmid purification

systems (Qiagen Inc., Chatsworth, CA).

Appropriate linearized sense and anti-sense

strands were constructed using restriction endonuclease digestion. The linearized DNA
strands were diluted to 0.5 pg/pl and stored at -20 °C in TE buffer, pH 8.0, until ready for
riboprobe synthesis.

Throughout this process, PC/Gene Software was utilized for

verifying restriction sites with restriction maps, and 1 % agarose gel electrophoresis used
to verify the efficiency o f cutting, proper fragment lengths, and orientation of the
fragment.
PPGF-A:
The genomic sequence for PDGF-A chain was identified by Collins and co
workers (20). The cDNA for PDGF-A was available in our laboratory as a pBluescript
SK+ insert in a Sal I/Sac II site. Sal I and T 3 make a 368 bp sense strand, and Sty I and
T7 make a 321 bp antisense strand.
PDGF-B:
The original genomic sequence was identified by Aaronson and co-workers (143).
In our laboratory, the PDGF-B cDNA was initially cut out o f pUC-13 and oriented into a
Xba I/Sma I site in pBluescript SK+. The original length was 272 bp; however, Xba I did
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not give complete digestion when trying to linearize the DNA. An alternate Bst XI site
was found that provided proper cutting, but gave 3’-overhangs.

Treatment o f this

antisense chain with DNA polymerase I Klenow fragment prior to probe synthesis
provided blunt ends through exo- and endonuclease activity (another possibility for
antisense chain linearization is to use Not I which leaves acceptable 5’ overhangs). The
final length o f both sense and antisense chains was 265 bp. Sma I and T3 make sense
while Bst XI and Klenow fragment (or Not I) and T 7 make antisense.
bFGF:
The original nucleotide sequence o f bFGF was identified by Abraham et al. (1). In
our laboratory, the cDNA for bFGF was available in pSK+ in an Eco RV site. The 704 bp
segment was linearized with Xho I and T3 to make sense and Bam HI and T7 to make
antisense.
TGF-B1:
The original cDNA sequence was desribed by Qian et al. (138). In our laboratory,
the cDNA was available in pBluescript II KS+ as a 985 bp fragment in a Sma I/Bam HI
site. The restriction sites between the promoters are reversed in pKS+ when compared to
the pSK+ positions. Treatment with Eco RI (or Sma I) and T7 make sense, while Bam HI
and T3 make antisense.
3

sS-CTP Riboprobe Synthesis
All enzymes and buffers for 3SS-CTP riboprobe syntheses were purchased from

Promega Corporation (Madison, WI). Linearized sense and anti-sense cDNA strands
were transcribed in the presence of 90 pCi 35 S-CTP (Dupont de Nemours, Boston, MA) in
a standard 20 pi transcription reaction containing transcription buffer (5x), 100 mM DTT.
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RNAse inhibitor, ATP, UTP, CTP, GTP, I pg linearized cDNA and the appropriate RNA
polymerase T3 or T7. If a 3’ overhang existed on the cDNA, it was treated with DNA
polymerase I Klenow fragment (5 units/pg DNA) for 15 minutes at room temperature.
Transcription proceeded for 2 hours at 37 °C, and the reaction stopped with DNAse.
Radionucleotide incorporation was measured using PEI cellulose-F chromatography paper
(EM Industries, Inc., Gibbstown, NJ) and phosphorimager analysis (Molecular Dynamics).
The samples were then purified on a Sephadex G-50 spin column (5 Prime —> 3 Prime,
Inc., Boulder, CO). The DNA was eluted, treated with 10 mg/ml tRNA and 100 mM
DTT, and if probe length exceeded 800 bp, subjected to limited alkaline hydrolysis for a
final length of 150 bp. Alkaline hydrolysis consisted o f incubation at 60 °C in 0.2 M
Na2C03 and 0.2 M NaHC03 for a calculated amount of time. The time for alkaline
hydrolysis was determined according to the following calculation: initial length of probe
(in kb) - 0.15 kb

0.11 kb-min'1x initial length o f probe x 0.15 kb. Small volume aliquots

were prepared, the pH was neutralized, and the probe precipitated in cold 100% ethanol
(2.5 x volume) and 3 M NaOAc, pH 7.5 and stored at -70 °C until use. On the day of use,
an aliquot was centrifuged, the supernatant removed, and the pellet treated with cold 70%
ethanol for 5 minutes. The solution was centrifuged again and the supernatant removed.
The probe pellet was dried down and resuspended in 20 mM DTT and formamide. Prior
to use for in situ hybridization, a 1 pi sample of the probe was added to 6 ml scintillation
cocktail in order to measure radioactivity (desired results 106 CPM/pl).
In situ Hybridization
The in situ hybridization methods used in this laboratory are primarily based on
those described by Wilcox (191) for formalin-fixed, paraffin-embedded tissues.
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equipment used on day 1 of this protocol was treated with either 3% hydrogen peroxide
or 0.5M NaOH to destroy RNAse enzyme. Also, all solutions made for day 1 were
prepared with RNAse-free materials and diethyl pyrocarbonate (DEPC; Sigma) treated
dH20 . Slides were cleared and deparaffinized in xylene and graded alcohols. The slides
were washed in 0.5 x SSC for 10 minutes, deproteinated with a 5 pg/ml solution of
proteinase K tritirachium album (Amresco, Solon, Ohio) for 10 minutes at room
temperature, and rinsed 3 times in PBS.

The slides were post-fixed in 4%

paraformaldehyde (Sigma) for 10 minutes at 4 °C, and rinsed 3 times in PBS. The were
then covered with 200 |xl prehybridization stock containing 50% dextran sulfate, 50x
Denhardt's solution, EDTA, Tris, NaCl, DEPC-H2O, and formamide in a humidity
chamber for 2 hours at approximately 40 °C. The prehybridization solution was allowed
to drip off, and the tissues were incubated with 100 |il hybridization solution containing 1
M DTT, 10 mg/ml yeast tRNA, and radioactive probe at 106 CPM/slide in the humidity
chamber (Isotemp Incubator, Fisher Scientific) at 55 °C overnight.
Solutions and equipment used on day 2 of this protocol were not RNAse-free.
The slides were removed from the incubator after the hybridization step and washed in a
low stringency solution o f 2 x SSC and 10 mM fi-ME-EDTA for 20 minutes. Slides were
treated to a 40 pg/ml RNAse A solution (Sigma) for 30 minutes at room temperature to
digest unhybridized probe. Slides were washed again in the low stringency solution for 20
minutes, followed by four 1 hour washes in a high stringency solution of 0.1 x SSC and 10
mM 3-ME/l mM EDTA at 55 °C. Slides were rinsed in 0.5 x SSC for 20 minutes, and
then serially dehydrated in graded alcohols containing 0.1 x SSC and 1 mM DTT. Slides
were allowed to air dry overnight.
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Emulsion. Developing, and Counterstaining
Kodak NTB-2 emulsion (Eastman Kodak Co.) was heated at 42 °C for several
hours prior to dipping. All slides were placed inverted in specially designed slide holders.
In absolute darkness, emulsion was gently mixed with an equal amount o f warmed dH20
and poured into a glass slide holder immersed in a pre-heated H20 bath. Slides were
dipped into the emulsion mixture for approximately 1 second, removed and placed
inverted in an incubator box containing dessicant. After all slides were dipped, the box
was sealed shut and the slides allowed to air dry overnight. The next day, in absolute
darkness, slides were transferred to individual black boxes (containing dessicant), which
were wrapped in aluminum foil, labeled, and stored in a separate incubator box at 4 °C for
10 weeks.
After the appropriate amount of time, the slides were brought to room
temperature. Kodak Dektol Developer (Eastman Kodak Co.) was prepared (17 g.
developer to 250 ml dH20 at 32 - 38 °C) and diluted with an equal amount o f dH20 .
Kodak Fixer (Eastman Kodak Co.) was also prepared (45 g. fixer to 250 ml dH20). In
absolute darkness, slides were removed from the black boxes and placed in slide holders.
Slides were dipped in developer for 4 minutes, dH20 for 30 seconds, and fixer for 5
minutes, after which they were placed in room temperature dH20 until all slides were
completed.

Slides were washed under slowly-running tap water for 15 minutes and

allowed to air dry overnight.
The next day slides were cleared in xylene and rehydrated in graded alcohols.
Slides were counterstained in hematoxylin dye (Surgipath Harris Formula, Surgical
Medical Laboratories, Inc., Richmond, IL) for 2 minutes, followed by a 2% glacial acetic
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acid rinse for 30 seconds. Slides were soaked in dH20 and treated with a bluing agent
(sodium bicarbonate, lithium carbonate in dH20 ) for 30 seconds. Slides were soaked in
dH20, 95% ethanol, and treated with eosin-y stain
Laboratories, Inc.) for 1 minute.

(Surgipath, Surgical Medical

Slides were dehydrated, cleared, air dried, and

coverslipped with Accumount 60 Mounting Medium (Baxter Health Care Corp.).
Microscopic evaluation o f in situ hybridization slides was performed using the
Image-1 system linked to a Sony DXC-151 CCD camera and Nikon Optiphot-2
microscope. Pixel threshold intensity gray levels were set, and secondary filters were
established to cover a narrow range of silver grain size. A region o f interest was made
covering approximately 50 pm2. Automatic silver grain counts were performed in both the
endothelial and medial layers in vessel cross-sections.

Data from duplicate samples were

averaged, and mean values for sense were subtracted from those for anti-sense to provide
an overall value for specific signal. Data were represented as number o f grains per 50 pm2
of tissue for wall area measurement, and as number o f grains per 15 pm luminal perimeter
for endothelial measurements.
Statistical Analysis
Data were stored and analyzed on personal computers using Instat 2 (Graphpad
Software, v. 2.02), Excel (Microsoft, v. 5.0), and Sigma Plot (Jandel Scientific, v. 2.0).
Morphological data were analyzed using a two-way ANOVA with post-hoc Bonferronicorrected paired and unpaired T-tests.

This two-way ANOVA allows analyses of

between- (time) and within- (treatment) subjects and considers interaction effects. Flow,
WSR, and pressure data were analyzed using a repeated measures one-way ANOVA (a
two-way ANOVA without replication) with post-hoc Bonferroni and Student-Newman-
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Keuls tests. Subjective eNOS scores were analyzed using the non-parametric Wilcoxon
signed rank test for data from non-Gaussian populations. All other data were analyzed
using a two-tailed paired Student’s T-test. All data, means and variances were tested for
normality using ANOVA-associated Normality tests.

Unless otherwise specified, data

were presented as mean values ± SEM, and the null hypothesis was rejected at an
uncorrected a level of 0.05. Paul Kolm, PhJD., and members of the Lewis Hall computer
center were available for consultation.
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CHAPTER V
RAT MESENTERIC FLOW MODEL INDUCES SIGNIFICANT INCREASES
IN SHEAR STRESS WITH POSSIBLE CONTRIBUTION FROM
WALL STRESS

Introduction
Vascular homeostasis is continuously influenced by the mechanical forces created
by transmural pressure and blood flow.

Arterial pressure is directly related to

circumferential wall stress and affects primarily medial and adventitial components of the
vessel wall. Blood flow exerts tangential shear stress acting predominantly on the luminal
aspect of intimal ECs.

This shear stress can also affect underlying SMCs through

interstitial fluid flow (3, 4, 188). These biophysical forces have been implicated in the
pathophysiology of various vascular disorders such as localization of atherosclerotic foci
and formation of intimal, subintimal, and medial neoplasias. A primary concern in studies
of the pathophysiology o f hemodynamic stimuli is the inability to completely separate the
influence of wall stress from that of shear stress. Even when transmural pressure is held
constant, the influence o f flow-induced vasodilation leading to increased wall stress
through cell stretch warrants consideration. The aim o f the experiments in this chapter
was to characterize a unique rat mesenteric flow model in order to differentiate the roles
of wall stress and shear stress in mediating vascular remodeling under in vivo conditions.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

61

Results
Control and post-ligation hemodynamic parameter data are summarized in Table 51. Eight rats were successfully evaluated for this part of the study. Neither mean arterial
(carotid artery) nor local mesenteric pressures changed significantly post-ligation. Prior to
any ligations, ileal artery blood flow averaged 65 ± 0.08 ml/min. After ligation of only the
proximal branch off the sixth ileal artery, ileal artery blood flow decreased 35 ± 5% (data
not shown). For control conditions before any ligations, it was assumed that flow through
the second-order branch artery was equal to half of the flow through the parent ileal
artery. This assumption seems reasonable considering that the in vivo inner diameters of
the two branches were similar under control conditions (220 ± 18 pm distal vs. 213 ± 13
pm proximal branch). After ligation of the proximal branch, the flow through the ileal
artery and the only remaining branch would be equal. Given this assumption, after ligation
of the proximal second-order branch of the sixth ileal artery and ligation of the adjacent
fifth ileal artery, blood flows through the supplying ileal artery and distal branch were
increased 36 ± 13% (p < 0.01) and 170 ± 25% (p < 0.001), respectively, relative to pre
ligation control conditions. Significant flow-induced dilation was demonstrated in the ileal
artery (~7%; p < 0.001), while the second-order artery did not experience a significant
increase (-5%) in internal diameter post-ligation.

The ileal artery exhibited a

nonsignificant (-10%) increase in calculated average WSR, while average WSR in the
second-order branch increased 118 ± 27% (p < 0.001). Measurements of completely
dilated vessels indicate that control ileal arteries possess ~6% tone while control secondorder arteries have -9% tone under resting conditions (data not shown).
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TABLE 5-1: Control and post-ligation hemodynamic parameters

Parameter:
MAP (mm Hg)
Second-order branch pressure (mm Hg)
Ileal artery blood flow (ml/min)
Second-order branch blood flow (ml/min)
Internal radius (|om): ileal artery
Internal radius (tun): second-order branch
WSR (sec'1): ileal artery
WSR (sec*1): second-order branch

Control
111.8 ±4.3 (8)
91.0 ±2.6 (6)
0.65 ±0.08 (8)
0.33 ±0.04 (8)
150.3 ±6.3 (8)
130.2 ±8.9 (7)
4125 ±468 (8)
3832 ± 647 (7)

Post-ligation
119.4 ± 3 .4 (8)
88.3 ± 5.7 (6)
0.83 ±0.07(8)**
0.84 ±0.07 (8)***
160.7 ± 7.3 (7)***
136.8 ± 6 .0 (7)
4545 ± 630 (8)
7618 ± 1193 (7)***

Data represent control and post-ligation mean ± standard error o f the mean for
arterial pressure, blood flow, vessel internal radius, and calculated wall shear rate (WSR):
[(4Q)/(7rr3) where Q = blood flow (ml/sec) and r = vessel radius (cm)]. Sample size is
indicated in parentheses. Data were analyzed using a repeated measures ANOVA with a
post-hoc Student-Newman-Keuls test and an a = 0.05. ** p < 0.01; *** p < 0.001
versus pre-ligation values.
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Discussion
This chapter attempts to characterize a modification of an existing mesenteric
collateral flow model established by Unthank et al. (181) that utilizes a series o f arterial
ligations (Fig. 4-1) which force a supplying ileal artery to feed the arterial arcade and
bowel in the flow-dependent section. Upon setting the ligations, blood flow through the
feeding ileal artery and its second-order branch increased significantly (Table 5-1). Acute
flow-induced dilation exhibited in the ileal artery (~7%) offset any significant increase in
calculated WSR for this vessel. The second-order artery, however, did not significantly
dilate resulting in a highly significant doubling of its calculated WSR. Considering the
acute flow-induced dilation experienced by the high flow ileal and second-order branches
(+7%; +5.4%, respectively) and the acute changes observed in WSR in these vessels
(+10%; +100%, respectively), we believe the primary stimulus for both ileal and branch
vessels is shear stress; moreover, the ileal artery may be exposed to acute flow-induced
cell stretch and its associated wall stress which may contribute to the remodeling
evidenced in this vessel. After administration of a vasodilator cocktail, the ileal artery
demonstrated -6% tone while the second-order branch possessed -9% tone under control
conditions. Based on measurements o f wall area, the assumption o f conservation of wall
area during active dilation, and surgical manipulation perhaps injuring the response, we
believe that the maximum change in acute wall stress that could have occurred in these
vessels would be -10%.

This may be an adequate stimulus to induce acute arterial

remodeling in these vessels.

Co-existence o f these flow-induced stresses and their

combined influence on local vasculature accurately portrays normal conditions
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experienced by blood vessels in vivo. As discussed in Chapter 6, chronic wall stress
appears to remain stable (as measured through wall thicknessilumen diameter ratios),
suggesting that flow-induced stresses are temporally normalized by vascular adaptations
involving luminal enlargement and wall hypertrophy.
A primary concern in developing this model was abolition of any influence of
altered arterial pressure, since pressure-induced wall tension alone can stimulate an array
of biochemical and molecular signals (33, 118, 146).

In addition, the influence of

pressure-induced myogenic tone contributing to alterations in wall stress must be
considered.

In this model, neither mean carotid nor local mesenteric arterial pressures

changed significantly post-ligation (Table 5-1). In a recent paper by Unthank et al. (181),
3 to 4 sequential ileal arteries were ligated creating a region containing 44-55 1A
arterioles subject to collateral flow through the two boundary ileal arteries. Collateral
blood flow increased approximately 274% through the supplying ileal arteries; however,
local mesenteric pressure at the center of the collateral-dependent region decreased
approximately 53%. A reduction in the passive diameters of both arteries and arterioles
from the decrease in pressure at this location could alter wall stress and shear stress and
potentially influence their growth response. The model used in the current study allows
specific examination of flow-induced stresses without the influence of pressure-mediated
stimuli.
This model allows high flow and control arteries for both ileal and second-order
branches to be studied in the same animal. This greatly reduces the individual variation
inherent when using different animals for control and treatment groups. Standardization
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of the exact site for vessels to be ligated, as well as the sites to obtain unligated control
vessels, also decreases individual variation.

In addition, for purposes of maintaining

consistency, diagrams of the mesenteric artery arrangement were made during the
surgeries for each rat. The length o f the collateral flow-dependent region was measured
and the number of 1A arterioles feeding the intestinal wall in the region was counted.
The practicality o f performing the surgeries to establish this model also offers several
advantages.

Through the use of Na^-pentobarbital (60 mg/kg IM) as our choice of

anesthetic, rats generally achieve a surgical level o f anesthesia within 30 minutes, maintain
this level o f anesthesia for the duration of the surgery (approximately 45 minutes), and
recover completely after an additional 1 to 2 hours.
supplemental anesthetic given during the surgeries.

Only on rare occasion was
After performing the medial

laparotomy, the cecum and adjacent ileum were easily identified and exteriorized.
Through the use of a dissecting microscope, the overall architecture of the mesenteric
vasculature was easily visualized and the exact location for setting the ligations was easily
and rapidly determined. Separating the artery from its adjacent vein proved troublesome,
but by using a curved suture needle ligating only the artery was made easier.

These

various factors specific to this model help establish it as a unique and useful experimental
tool that can be used to address hemodynamic forces and their effects on vascular
physiology under in vivo conditions.
In conclusion, this chapter details a novel experimental model that allows
manipulation of hemodynamic parameters under in vivo normotensive conditions. The
primary stimulus for the ileal and second-order arteries was determined to be flow-induced
shear stress, with possible contribution from stretch-induced wall stress for the larger
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vessel. Considering the arterial remodeling discussed in the following chapters, this rat
mesenteric flow model permits an exclusive flow stimulus leading to significant in vivo
growth regulation in small mesenteric arteries and allows continued analyses of possible
signaling factors involved.
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CHAPTER VI
FLOW INDUCES ARTERIAL LUMINAL ENLARGEMENT AND MEDIAL
WALL HYPERTROPHY THROUGH ENDOTHELIAL AND SMOOTH MUSCLE
NUCLEAR REPLICATION AND CELLULAR HYPERPLASIA
Introduction
Arterial remodeling from hemodynamic stresses has been demonstrated using
various experimental preparations on a variety o f cell types. Unthank and co-workers
showed elevated collateral flow stimulates luminal enlargement (179) and medial wall
hypertrophy (181) in rat small mesenteric arteries. Langille and co-workers found blood
flow directly regulates developmental proliferation o f cellular and extracellular vessel wall
constituents in young rabbits (91) in addition to stimulating remodeling of the vessel wall
in adult rabbits (92, 186). In contrast, Kraiss et al. (86) showed SMC proliferation to be
inversely correlated with shear stress using polytetrafluoroethylene graft implants in
baboons.

Other models of experimental atherogenesis (197), in situ perfused organ

culture (13), and arteriovenous shunts (111) have revealed differential results concerning
the influence of hemodynamic stresses on arterial wall restructuring. In terms of cellular
mechanisms behind structural remodeling o f the arterial wall associated with changes in
lumen diameter, EC and SMC hyperplasia and/or cellular hypertrophy, reorganization of
existing wall components, cellular migration, alterations in ECM constituents, cell death
and removal, or combinations of all o f these may be involved.
As discussed in the previous chapter, the primary stimulus in the experimental
model presented here is flow-induced shear stress with possible contribution of acute wall
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stress in the ileal artery. The aim of the experiments in this current chapter was to
characterize the remodeling response o f small mesenteric arteries exposed to elevated
blood flow in vivo. Flow-induced arterial remodeling in terms of luminal enlargement and
medial wall hypertrophy was analyzed for both treatment and time effects over a 7 day
period. The endothelial and smooth muscle cellular mechanisms contributing to these
gross morphological alterations were examined through immunocytochemical approaches
and nuclear profile analyses.
Results
Rat M esenteric Flow M odel
Thirty rats were successfully analyzed for this part o f the experiment.

During

establishment of the arterial ligations according to the mesenteric flow model (Figure 4-1),
several parameters were measured for purposes of maintaining consistency throughout the
experiment. The mean length of the flow-dependent region, defined as the section o f the
intestinal wall subject to blood flow from the unligated ileal artery, was 41.83 ± 0.88 mm.
The number of 1A arterioles that fed the intestinal wall in the flow-dependent region was
19.3 ± 0.67, while the MAP (measured for purposes of setting individual pressures for
perfusion-fixation) was 89.3 ± 1.52 mm Hg.
M orphological Analysis
Figures 6-1 and 6-2 graphically illustrate flow-induced alterations in inside lumen
diameter and medial wall area, respectively, for ileal and second-order arteries after 1,3.
and 7 days of increased blood flow. The 2-way ANOVA shows there is no significant
interaction (p = 0.11) between flow and duration o f exposure for changes in ileal artery
lumen diameter. Significant increases in lumen diameters were observed in both control (p
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< 0.002) and high flow (p < 0.005) ileal arteries with time. Post-hoc Bonferroni-adjusted
statistics indicated a significant increase (+13%) in lumen diameter for ileal arteries
exposed to high flow for 7 days when compared to same animal control vessels. The 2way ANOVA demonstrated a significant (p = 0.004) interaction between flow and the
duration of exposure for changes in lumen diameter in the second-order arteries. Lumen
diameters for control second-order arteries did not change significantly with time. Posthoc independent comparisons revealed +14% and +38% increases in lumen diameter for
high-flow second-order vessels when compared to same animal controls after exposure to
flow for 3 and 7 days, respectively. The 2-way ANOVA for flow-induced changes in
medial wall area (Fig. 6-2) suggested significant interactions between flow and time exist
for both the ileal artery (p = 0.014) and the second-order artery (p = 0.005). Post-hoc
analysis indicated that after 7 days o f increased flow, ileal artery wall area was significantly
(+58%) elevated compared to its same animal control.

Similarly, post-hoc analyses

showed that high flow second-order arteries exhibited significant medial wall area
enlargement compared to corresponding control vessels after 3 (+53%) and 7 (+120%)
days of elevated flow. Medial wall areas for control ileal and second-order arteries did not
change significantly with time.
Figure 6-3 compares the sensitivity of the ileal artery to that o f the smaller secondorder branch in terms of flow-induced changes in inside diameter and medial wall area (as
a percent change compared to relative control vessels).

These data clearly show a
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Figure 6-1. Flow-Induced Alterations in Lumen Diameter. Flow-induced alterations in
lumen diameter for ileal and second-order vessels show no interaction between high flow
and time for ileal artery luminal enlargement, with both control and treatment vessels
experiencing significant increases with time. Significant interactions between flow and time
were demonstrated for the second-order artery lumen diameter.

Post-hoc independent

comparisons of control versus treatment for each time point are indicated. Data were
evaluated with a 2-way ANOVA using post-hoc Bonferroni-corrected T-tests.

Values

represent mean ± SEM, and n = 10 for each group. * p < 0.05, ** p < 0.01, *** p <
0.001 versus control; 'S’ p < 0.05, tir,cuJ p < 0.01 versus day.
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Figure 6-2. Flow-Induced Alterations in Medial Wall Area. Flow-induced alterations
in medial wall area for ileal and second-order vessels. Significant interactions between
flow and time were demonstrated for changes in ileal and second-order artery wall area.
Post-hoc independent comparisons o f control versus treatment for each time point are
indicated.

Data were evaluated with a 2-way ANOVA using post-hoc Bonferroni-

corrected T-tests. Values represent mean ± SEM, and n = 10 for each group. * p < 0.05,
** p < 0.01, *** p < 0.001 versus control;

p < 0.05, 'fr'fi’ p < 0.01 versus day.
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Percent Change in Lumen Diameter and Medial Wall Area.

The

percent change in lumen diameter and medial wall area between control and high flow
vessels suggest a “dose-dependency” in terms of the magnitude of the flow-induced
response. The percent changes in medial wall area far exceed those evidenced for luminal
expansion in both vessels in response to flow. Values represent mean ± SEM, and n = 10
for each group. * p < 0.05.
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significantly heightened response for the second-order artery compared to the larger ileal
artery for flow-induced alterations after 7 days in both lumen diameter and wall area.
Figure 6-3 also indicates that the relative increases in medial wall area far exceed the
changes observed in inside diameter after exposure to elevated flow. Figures 6-4 and 6-5
respectively illustrate medial wall thickness.lumen diameter ratios and medial wall
arearlumen area ratios. No significant differences were detected for high flow vessels
compared to same animal control vessels at any time.
ICC Resultsfo r PCNA/SMC Nuclear Profile Analysis
In order to determine the ratio o f medial SMCs undergoing active DNA replication
and cell division, ICC was performed for PCNA and medial SMC nuclei were counted.
Figure 6-6 illustrates the percent PCNA-positive medial SMC nuclei for high flow vessels
divided by those for control vessels. Data were best represented in this fashion to account
for elevated basal PCNA counts, which averaged between 7% and 21% in both ileal and
branch arteries. These data clearly indicate ileal artery medial SMCs undergo significant
DNA synthesis after 3 and 7 days of elevated blood flow (+189%, +179% compared to
same animal controls, respectively), while significant DNA synthesis occurs in the secondorder arterial branch after 7 days (+407% compared to control).
In the case o f polyploidy whereby cells undergo DNA replication without cell
division, cells can stain positive for PCNA without a change in cell number (14). Figure
6-7 shows absolute medial nuclear counts with significant SMC hyperplasia indicated in
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Medial Wall Thickness:Lumen Diameter Ratio.

Medial wall

thicknessrlumen diameter ratios for ileal and second-order arteries show no significant
differences between high flow and control vessels. These data show that similar increases
are observed in wall thickness when compared to luminal expansion, indicating that
chronic wall stress is stabilized in the presence o f normal arterial pressure.
represent mean ± SEM, and n = 10 for each group.
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Figure 6-5. Medial Wall Area to Lumen Area Ratio. Medial wall area:lumen area
ratios for ileal and second-order arteries show no significant differences between high
flow and control vessels. These data show that similar increases are observed in medial
wall hypertrophy when compared to luminal area and indicate that chronic wall stress is
stabilized in the presence of normal arterial pressure. Values represent mean ± SEM, and
n = 10 for each group.
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Figure 6-6. Medial Wall SMC PCNA Ratio. Immunocytochemical results for medial
SMC PCNA in ileal and second-order arteries. Data represent percent PCNA-positive
medial SMC nuclei for high flow vessels divided by those for control vessels for both the
ileal artery and second-order branch. Data suggest significant DNAsynthesis in the media
of SMCs after exposure to elevated flow for 3 and 7 days. Values represent mean ±
SEM, and n = 6 for each group. * p < 0.05, ** p < 0.01 versus control.
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Absolute Medial Wall SMC Nuclear Counts.
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This data indicate

significantly increased cell division after in vivo exposure to flow for 7 days for both ileal
and second-order arteries. Significant differences in absolute nuclei number were not
detected between control and high flow vessels after 1 or 3 days. Values represent mean
± SEM, with n = 6 for each group. * p < 0.05 versus control.
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Figure 6-8. Normalized Medial Wall SMC Nuclear Counts. This data suggest that,
at almost all time points, increased cell division is proportional to increased medial wall
area to maintain a constant SMC density.

The second-order vessel demonstrates a

significant decrease in cell density upon exposure to elevated flow after 7 days,
suggesting that cellular hypertrophy and perhaps nuclear polyploidy may be involved in
this vessel at this time point. Alternatively, SMCs in this vessel may be actively engaged
in the cell cycle prior to cytokinesis. Values represent mean ± SEM, with n = 6 for each
group. * p < 0.05 versus control.
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both high flow ileal (+30%; p < 0.04) and second-order (+73%; p < 0.05) arteries after 7
days. When data were normalized to medial wall area (Fig.6-8), SMC nuclear density
remains constant in the presence o f enlarged wall areas for almost all time points in both
the ileal and second-order arteries. However, data indicate that the second-order artery
experienced significant SMC hypertrophy after exposure to elevated flow for 7 days, as
shown by a decreased (-22%; p < 0.02) medial nuclear density concomitant with an
increased wall area. These results imply that flow-mediated vessel wall remodeling in vivo
occurs primarily through SMC hyperplasia with some contribution of cellular hypertrophy
in small branching mesenteric arteries. Additionally, the second-order branch may be
experiencing nuclear polyploidy after exposure to flow for 7 days, as suggested by
increased nuclear replication in the presence o f a decreased nuclear (and cellular) density.
EC Nuclear Profile Analysis
Figures 6-9 and 6-10 illustrate absolute and normalized intimal EC nuclear counts,
respectively. At 1, 3, and 7 days o f increased flow, absolute EC nuclear counts were
significantly elevated in both the ileal (+17%, +50%, +65%; respectively) and secondorder (+33%, +89%, +81%; respectively) arteries when compared to same animal control
vessels. When data were normalized to 100 pm luminal perimeter, only in the I day
second-order vessels did the increase in EC counts not reach significance (p = 0.07).
Percent changes for normalized data for the ileal and second-order artery at 1, 3, and 7
days were +17%, +38%, and +44%, and +23%, +67%, and +36%, respectively. These
results suggest that after 24 hours o f increased blood flow in vivo, rat mesenteric arterial
ECs are stimulated to undergo significant cellular replication leading to increased EC
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Figure 6-9. Absolute Intimal EC Nuclear Counts. These results indicate that once
blood flow is increased, flow-mediated stresses are rapidly sensed by intimal endothelium
leading to EC replication after 24 hours continuing through 7 days. Values represent
mean ± SEM, with n = 10 for the ileal artery group and n = 8 for the second-order branch
group. * p < 0.05, *** p < 0.001, **** p < 0.0001 versus control.
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Normalized Intimal EC Nuclear Counts.
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These data represent intimal EC

nuclear counts normalized to 100 pm luminal perimeter.

The flow-mediated stress

stimulus is rapidly sensed by the endothelium, leading to significant EC replication in the
ileal artery after 24 hours, and in the second-order vessel after 3 days. Values represent
mean ± SEM, with n = 10 for the ileal artery group and n = 8 for the second-order branch
group. * p < 0.05, *** p < 0.001, **** p < 0.0001 versus control.
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densities. This exaggerated EC hyperplasia persists through 7 days of increased flow.
Discussion
In this model, significant adaptations occurred in terms o f luminal enlargement and
medial wall hypertrophy in the ileal and second-order arteries after exposure to elevated
flow (Figs. 6-1, 6-2). Generally, these morphological alterations were dependent upon the
duration of in vivo flow exposure between I and 7 days. Deal artery lumen diameters of
both control and high flow vessels increased significantly with time. This implies that
significant developmental growth in terms of luminal enlargement may be occurring in
normal -10 week old rat mesenteric ileal arteries over a 7 day period. Considering the
significant interactions between day and treatment for all other morphological data,
however, the authors believe that age was not a major factor influencing the results of this
study. In agreement, Unthank et al. (180) found minimal bowel growth occurs in normal
Wistar-Kyoto rats from 10 to 20 weeks of age.
Several important points should be mentioned when analyzing these flow-induced
morphological data. A heightened adaptive response of the smaller second-order artery is
noticed when compared to that of the larger ileal artery (Fig. 6-3). Percent changes in
lumen diameter of high flow ileal arteries compared to same animal controls range
between 1% and 13%, while the same changes for the second-order vessels range between
10% and 38%. Similarly, percent changes in medial wall area of high flow ileal arteries
compared to same animal controls range between -9% and 58%, while the same changes
for the second-order vessels range between 18% and 120%. Considering that the increase
in blood flow and calculated WSR were significantly higher in the smaller second-order
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branch compared to the parent ileal artery, the degree o f flow-mediated vascular
remodeling is suggested to be dependent on the magnitude o f the flow stimulus in
mesenteric vasculature.

Another important observation concerns the greater changes

observed in medial wall area compared to those found in luminal diameter. This suggests
that a more dramatic adaptive response occurs affecting the circumferential component as
opposed to the radial component o f the vessel wall, supporting a role for wall stress in
mediating these events. This is somewhat counter-intuitive, considering that the normal
adaptation to increased blood flow is luminal enlargement to restore shear stress towards
normal.

In this model, highly significant increases in wall area, more consistent with

changes in transmural pressure or wall stress, occur in the presence of unaltered arterial
pressures.

These results support a role for wall stress in addition to shear stress in

contributing to flow-induced vascular remodeling.

However, these results also raise

questions concerning the signal transduction pathways that might be stimulated from
increased blood flow in vivo.

A possible role for flow-regulated growth factors in

mediating in vivo vascular growth is addressed in the subsequent chapters.
The flow-mediated growth alterations evidenced in this study are structural rather
than functional, because all vessels were maximally relaxed when formalin-fixed. This
represents forms of vascular remodeling, as proposed by Langille and O’Donnell (92) in
their work with rabbit common carotid arteries. These authors found a 21% decrease in
lumen diameters in arteries subject to 70% flow reduction after 2 weeks. Based on the
results that papaverine did not attenuate the response, they suggested that the decreased
lumen diameters were the result o f chronic flow-dependent structural modifications
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occurring in the arterial wall.

Results from the current study indicate that structural

modifications from increased flow occur rapidly in the arterial wall and become
statistically significant after exposure to elevated flow for 3 days.
Through a derivation o f the Laplace relation for wall tension, if arterial pressure is
held constant, a stable wall thickness:lumen diameter ratio implies a normal wall stress. In
the current model, a constant wall thickness: diameter ratio between I and 7 days (Fig. 64) suggests that long-term wall stress remains constant. Luminal enlargement with medial
wall hypertrophy coincident with a normal wall thicknessidiameter ratio has been found by
several other investigators using models of experimental atherogenesis in monkey iliac
arteries (197) and collateral flow in rat mesenteric (179) and rabbit basilar arteries (96). In
addition, a stable medial wall area.lumen area (Fig. 6-5) is shown for both vessels at all
time points, indicating that the relative increases in wall area are similar to those for
luminal enlargement. However, Price and Skalak (147) used a computational arteriolar
network model based on a rat spinotrapezius transverse arteriole-collecting venule arcade
and suggested wall stress to be a primary determinant for arteriolar remodeling and
terminal arteriolar growth.

Computed arteriolar shear stresses did not correlate with

arteriolar remodeling in their model, but increased capillary shear stress did stimulate
formation of arterio-venous shunts. The relative contributions o f shear stress versus flowstimulated wall stress in regulating vascular growth and remodeling in arterioles and small
arteries necessitates further studies.

Based on the assumptions and results from the

current study as discussed in Chapter S, we believe the primary stimulus for these vessels
is shear stress with possible influence of acute flow-dependent wall stress in the ileal
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artery. These flow-induced forces, then, can stimulate arterial remodeling as evidenced in
this study.
Analysis o f SMC and EC nuclei can provide insight into the cellular mechanisms
governing structural remodeling of the arterial wall.

Immunocytochemical results for

PCNA (Fig. 6-6), a cell cycle-dependent cyclin (112), suggest ileal and second-order
branch medial SMCs undergo DNA replication after 3 days of in vivo exposure to
increased shear stress. Polyploid ceils with DNA replication in the absence of cytokinesis,
however, can erroneously be counted positive according to PCNA data (14). Absolute
medial wall SMC nuclear counts (Fig. 6-7) suggest cellular hyperplasia after 7 days o f
elevated flow in both the ileal and second-order arteries. These combined data imply that
elevated flow stimulates DNA replication and cellular division in medial SMCs under in
vivo conditions. Normal SMC nuclear densities for the ileal and second-order arteries
(Fig. 6-8) indicate that as medial wall hypertrophy occurs in response to elevated flow,
SMC hyperplasia maintains a constant SMC density. After exposure to high flow for 7
days, however, the second-order artery exhibited a slightly significant (p = 0.046) decrease
in SMC density. Medial wall hypertrophy in this vessel at this time point may involve a
combination of cellular hypertrophy and hyperplasia. Considering the PCNA data, nuclear
polyploidy may be involved also. This would be in agreement with the findings of Owens
(134) that large vessel SMC hypertrophy is often accompanied by development of nuclear
polyploidy in hypertensive animals. Owens suggested that polyploidy may act as a gene
amplification adaptive mechanism commensurate with an increased transcriptional
requirement of an enlarged cell. Another interpretation of the data for this vessel at this
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time point is that numerous SMCs may be actively engaged in the cell cycle prior to
cytokinesis. Once the remodeling process becomes complete, cellular hyperplasia and
diploidy would result.
These results characterizing medial wall growth in response to increased blood
flow are in concordance with the results from previous studies on developing animals.
Langille et al. (91) found significant decreases in lumen diameter and arterial wall mass
with significantly decreased DNA levels in flow-restricted carotid arteries in juvenile
rabbits. Wang and Prewitt (187) established a unique unilateral orchidectomy model in
developing rats and analyzed microvascular cremaster arterioles during normal or reduced
blood flow. After 3 weeks o f flow reduction due to a decreased demand, lumen diameters
and cross-sectional wall areas were significantly reduced when compared to the arterioles
of the control contralateral cremaster.

In recent work by Unthank et al. (179) on

collateral flow in rat mesenteric arteries, medial SMC hypertrophy was indicated after 1
week and SMC hyperplasia after 4 weeks contributing to medial wall expansion during
luminal enlargement. In contrast to these findings, Sterpetti et al. (171) found an inverse
relation between SMC growth rate and the magnitude of shear stress between 0 and 9
dyn/cm2 in cultured bovine aortic SMCs. In addition, DNA synthesis was significantly
reduced after 24 hours exposure to all levels of shear. However, direct exposure of the
underlying SMCs to shear stress is not a factor in the current study. Kraiss et al. (86),
through the use of vascular prostheses implanted in baboons, elicited a doubling o f aortic
blood flow with a resulting decrease in neointimal cross-sectional area, SMC proliferation,
and total SMC volume. The authors noted, however, that by using rigid prosthetic aortic
grafts, shear stress-induced vasoactive agents could not influence vessel diameter as would
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normally occur in an in vivo situation.

Lumen diameter, therefore, was altered only

through changes in neointimal thickness which implies flow-mediated wall stress as the
primary stimulus.
In the current study, intimal ECs were found to be rapidly and significantly
affected by exposure to increased blood flow as shown by dramatic EC hyperplasia after
24 hours (Fig. 6-9). This may be part o f an adaptive process coincident with increasing
lumen diameters to maintain a stable EC density along the lumen perimeter, however,
normalized EC counts in the high flow vessels indicate a dramatic endothelial replication
leading to increased EC densities in all vessels at almost all time points (Fig. 6-10). These
results are consistent with the results o f Unthank et al (179), who found the number of EC
nuclei in high flow collateral vessels -90% greater than those observed in control vessels
after both 1 and 4 weeks. Walpola et al. (186) discovered a 33% decrease in EC number
in ligated rabbit carotid arteries after 5 days exposure to an -80% decrease in blood flow.
Masuda et al. ( I l l ) found EC density significantly elevated in high flow canine carotid
arteries after 4 weeks; however, a corresponding increase in lumen diameter was not
detected.

The results from these studies, along with the present work, illustrate a

significant direct influence of blood flow and shear stress on intimal EC replication.
However, several investigators (28, 99, 119, 200) have found an inverse relation exists
between blood flow and EC division in cultured aortic ECs. In cell culture, however, flow
and shear stress stimulate a phenotypic change from a proliferative cell to a differentiated
cell. In addition, cultured cells are usually not pre-conditioned to flow, as is the case with
an in vivo preparation.

Under culture conditions, the influence of growth factors is

dramatically increased compared to the in vivo environment (104). These variables must
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be considered and caution used when comparing results between in vivo and in vitro
experiments.
In conclusion, the experiments described in this chapter examined the influence of
flow-associated stresses on arterial remodeling in an in vivo experimental model.
Significant luminal expansion and medial wall hypertrophy occurred in a time-dependent
fashion over a 7 day period in both ileal and second-order branching arteries. These
adaptations involved early and dramatic EC hyperplasia after 24 hours with subsequent
medial SMC DNA replication and cellular hyperplasia after 3 days.
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CHAPTER VII
INCREASES IN EXTRACELLULAR CONNECTIVE TISSUE CONTRIBUTE
TO FLOW-INDUCED VESSEL WALL HYPERTROPHY

Introduction
Results from the previous chapters demonstrated that significant luminal
enlargement and medial wall hypertrophy occurred in arteries exposed to flow-mediated
stresses between 1 and 7 days. Further examination revealed EC and SMC nuclear and
cellular replication as mechanisms contributing to the gross morphological changes
observed. In order to completely analyze flow-mediated alterations in the medial wall, the
contribution of extracellular connective tissue components must be considered.

Most

work in this area has focused on the endothelium and the ECM o f its basement membrane.
Ookawa et al. (133) determined that cultured aortic ECs were dependent upon the
presence o f underlying ECM components type IV collagen, heparan sulfate, chondroitin
sulfate, and dermatan sulfate for shear stress-induced cytoskeletal rearrangement. Wilson
et al. (194) found strain-stimulated DNA synthesis in cultured SMCs was dependent on
the composition o f the underlying matrix. Cyclical strain increased DNA synthesis in cells
grown on collagen I, fibronectin, and vitronectin, but did not affect cells grown on elastin
or laminin.

In addition, the responses to strain were dependent on the interactions

between

and Ovfis integrins and the specific matrix proteins.

The extracellular

components fibronectin, laminin, collagen type IV, and vitronectin have been found to
redistribute in terms o f fibril orientation and thickness (175, 176, 189) and to both increase
and decrease in response to shear stress (57, 132, 175, 176) and cyclic stretch (173). The
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aim of the present chapter is to characterize alterations in extracellular connective tissue of
the vessel wall after exposure to elevated blood flow and to determine its contribution to
flow-induced vessel wall hypertrophy under in vivo conditions.
Results
Figure 7-1 shows the percent extracellular connective tissue present in the medial
vessel wall for control and high flow ileal and second-order arteries.

No significant

differences were observed between control and high flow vessels at any time. The percent
of medial wall occupied by extracellular connective tissue in control arteries ranged from
29% to 34%, while in the high flow arteries ranged from 34% to 41%. These results
indicate that as the vessel wall hypertrophied in response to elevated flow, a concomitant
increase in medial extracellular connective tissue occurred.

Figure 7-2 shows

photomicrographs of trichrome-stained extracellular connective tissues for same animal
control and high flow vessels. The photo for the 7 day control animal contains a grid used
for stereologic assessment.
Discussion
The vessel medial wall is comprised of both cellular and extracellular components.
As discussed in Chapter 6, exposure to elevated blood flow stimulated DNA replication
and cellular hyperplasia in medial SMCs, thus contributing to significant medial wall
hypertrophy. As the medial wall remodeled in response to elevated flow, synthesis of
medial extracellular connective tissue was stimulated resulting in a constant percent
connective tissue in the medial wall at all times (Fig. 7-1). This increase in connective
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Figure 7-1. Percent Extracellular Connective Tissue in Medial Wall. A stable
percent extracellular connective tissue in the medial wall indicates that as the medial wall
hypertrophies, increased synthesis of medial connective tissue occurs to maintain a normal
medial wall environment. Values represent mean ± SEM, and n = 8 for each group.
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tissue acts to maintain normal cell-cell contact concomitant with an enlarged wall area. If
the extracellular components do not increase coincident with an enlarged wall area,
disruption of the local micro-environment could occur. Physiologic roles for these ECM
components include regulating EC adhesion, cellular spreading and migration, protein
synthesis and EC proliferation, and cellular differentiation (reviewed in 175). Alterations
in extracellular anatomy concomitant with altered SMC replication is essential for proper
maintenance of vascular homogeneity and regulation o f vascular physiology. In addition,
upregulation of various growth factors can directly influence the proliferation of
extracellular components. Ross (154) determined that PDGF can stimulate synthesis of
ECM components under in vitro conditions. The findings o f Sankar et al. (159) and
Roberts et al. (150) established a role for TGF-Pl in inducing in vitro fibronectin
expression and collagen formation, respectively. Ignotz and Massague (71) found TGFPl to increase expression of both fibronectin and collagen and to increase their
incorporation into the surrounding ECM. In the current study, TGF-PI transcription was
not altered by elevated flow; however, elevated levels of PDGF-A mRNA were detected
in the high flow ileal artery after 24 hours (Fig. 9-1). This increase in PDGF-A could
possibly enhance synthesis o f extracellular connective tissue as observed in this study.
One important role that has been proposed for the ECM is that it can act as an
extracellular store for various growth factors. Kelly et al. (80) found that the alternatively
spliced long-form of PDGF-A produced by cultured CHO cells was primarily localized to
the underlying matrix, the short-form of PDGF-A predominantly secreted, and PDGF-B
distributed between cells, ECM, and cell supernatant.

Subsequent work by the same

laboratory (41) found that plasmin released a mitogenically-active form of PDGF from
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underlying ECM in a variety of cell types. The ECM has also been identified as a storage
site for other growth factors including TGF-P and bFGF (21, reviewed in 41). Basic FGF
peptide has been found to localize to ECM-associated heparan sulfate proteoglycans,
where it can be released through the actions o f plastnin (157). This raises the possibility of
shear stress inducing EC-derived plasminogen activators and inhibitors, which could then
enzymatically release bFGF from the ECM through plasmin formation. Diamond et al.
(40) found TPA secretion to be significantly increased over control levels in cultured
HUVECs exposed to arterial levels of shear stress. In addition, release of these factors
from the ECM often occurs in a regulated fashion and may be mediated by specific
extracellular proteases such as chondroitin lyase (80) in addition to plasmin (22). This
ability of the ECM to sequester growth factors is pertinent to the present study, as our
results show upregulation of PDGF-A chain mRNA in SMCs and ECs surrounded by
extracellular connective tissue. Even if transcription of a certain factor is increased and
elevated protein levels result, physiologic activity may be significantly influenced by
storage in the ECM.
In conclusion, this chapter illustrates that as the medial wall hypertrophies in
response to elevated flow and its associated stresses in vivo, a concomitant increase in
extracellular connective tissue synthesis occurs to maintain normal vessel architecture.
This increase in ECM tissue could be directly stimulated by increased flow or, more likely,
involves stimulation from local action of flow-induced growth factors.
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CHAPTER VTII
ENDOTHELIAL-DERIVED NITRIC OXIDE MAY MEDIATE FLOWINDUCED VASCULAR REMODELING
Introduction
The ability of NO to mediate numerous aspects vascular function has been well
substantiated. Flow-induced increases in NO transcription, translation and release have
been demonstrated by numerous investigators using in vitro, in vivo, and isolated intact
vessel preparations (27, 28, 88, 103, 130, 169).

The feedback mechanism o f NO-

dependent vasoactive relaxation in response to elevated blood flow acts to influence
arterial tone and regulate blood supply to downstream tissues. Shear stress regulation o f
the endothelial isoform of NOS has been investigated at the transcript (126, 177) and
protein (126, 142) levels. In addition, the influence of cyclic strain on eNOS mRNA,
protein translation, release, and activity has been studied (9, 10). The aim of this current
chapter is to determine the influence o f flow-associated stresses on arterial eNOS levels in
our in vivo rat mesenteric flow model and to characterize the possible role o f NO in
mediating flow-induced arterial remodeling.
Results
Immunocytochemical results for eNOS in control and high flow vessels are
depicted in Figure 8-1. Blind scoring o f the specific eNOS signal was performed using a 0
- 4 grading scale, and scores were assessed using appropriate non-parametric statistics.
Data show significantly elevated eNOS scores in the high flow ileal artery at all time
points. After 1,3, and 7 days of elevated flow, eNOS scores were increased 49%, 55%,
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and 70%, respectively, in the high flow ileal arteries compared to controls. Only after 7
days of elevated flow did the eNOS scores reach significance for the second-order vessels
(+69%; p < 0.05). Endothelial NOS scores for 1 and 3-day high flow second-order
vessels were still elevated over controls (+28%, +24%, respectively), although statistical
significance was not reached. Photomicrographs o f eNOS-immunostained cross sections
are shown in Figure 8-2 with same animal control and high flow vessels.
Discussion
The role of NO in mediating many aspects o f vascular homeostasis is well
documented (24, 42, 82, 178). The importance o f NO in regulating vascular tone in the
mesenteric circulation has also been characterized by several investigators (48, 68, 73). In
addition, flow-dependent alterations in NO transcription and translation have been
elucidated using a variety o f experimental conditions (23, 62, 87, 88, 177); however,
studies analyzing shear stress regulation of eNOS are somewhat limited. Shear stressinduced increases in eNOS mRNA, protein, and release have been documented in cultured
BAECs and HUVECs (126, 127, 136, 142). In addition, cyclic strain has been found to
upregulate eNOS mRNA and protein expression in cultured BAECs (9, 10). However,
the influence o f shear stress on eNOS upregulation under in vivo conditions has yet to be
substantiated.
Results from the current study suggest that eNOS protein was elevated in arteries
exposed to increased blood flow after 24 hours (Fig. 8-1).

As discussed in Chapter 5,

the influence of flow-mediated wall stress in these vessels was lower than that of shear
stress.

These

results

are

consistent

with

previous

studies

demonstrating
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Figure 8-1. Endothelial NOS Protein Levels. Immunocytochemical results for eNOS
in control and high flow vessels indicate significantly elevated peptide levels in the ileal
artery after 1, 3, and 7 days of elevated flow, and significantly elevated levels in the
second-order artery after 7 days.

Blind scoring of the specific eNOS signal was

performed using a 0-4 grading scale, and statistical analysis was performed using a paired
replicate Wilcoxon signed rank test. Values represent mean ± SEM, with n = 10 for the
ileal artery group and n = 7 for the second-order artery group.
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that flow upregulates eNOS protein levels in cultured ECs (126, 142).

Several

investigators have found eNOS-mediated NO to be anti-mitogenic and inhibitory for DNA
synthesis in vascular SMCs (51, 52, 122). Our results showing increased eNOS protein
concomitant with early EC hyperplasia and luminal enlargement and medial wall
hypertrophy after 3 and 7 days, then, seem rather counter-intuitive. However, several
investigators have recently found that NO mediates the mitogenic effects of VEGF on
cultured microvascular venular ECs (120) and amplifies bFGF-induced mitogenesis in
primary rat aortic SMCs (61).

In addition, Ziche et al. (198) found that the NO-

generating agents SNP, ISDN, and GTN stimulated DNA synthesis in cultured ECs
isolated from coronary postcapillary venules. Results from treatment o f cells with LNMMA and methylene blue suggested endogenous NO can directly modulate EC
proliferation in the microvasculature. Subsequent work from the same laboratory (199)
demonstrated that substance P-induced angiogenesis in vivo in rabbit cornea and in vitro
in ECs isolated from coronary postcapillary venules were both potentiated by
administration o f SNP, ISDN, and GTN. Nitric oxide donation was found to significantly
enhance EC thymidine incorporation, cell number, and migration in vitro. Leibovich et al.
(97) determined that LPS-stimulated human monocyte-induced angiogenesis required an
L-arginine/NOS-dependent effector mechanism, as assessed in vivo in rat corneas and in
vitro by chemotaxis of HUVECs. Indeed, the results cited here, as well as those from the
present study, identify crucial roles for NO in mediating various vascular mechanisms
including cell migration and chemotaxis, cellular proliferation and nuclear replication,
angiogenesis, and synergism and potentiation with other vasoactive agents.
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In conclusion, this chapter suggests NO as a possible signaling factor in flow mediated vascular wall remodeling under in vivo conditions. Elevated eNOS levels 24
hours through 7 days after initiation o f the flow stimulus imply that NO, probably in
combination with cytokines or growth factors, is involved in the cellular changes leading
to flow-induced luminal enlargement and/or medial wall hypertrophy.
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CHAPTER IX

EARLY MEDIAL AND SUBSEQUENT ENDOTHELIAL PLATELET-DERIVED
GROWTH FACTOR-A CHAIN MAY BE INVOLVED IN FLOW-MEDIATED
VASCULAR REMODELING IN VIVO

Introduction
Platelet-derived growth factor is an important regulator of the vasculature that
influences cell migration, proliferation, chemotaxis, angiogenesis, cell-cell adhesion, and
cellular metabolism (1SS). PDGF exists as both the homo-dimers -AA and -BB or as the
heterodimer -AB. Upon binding to and dimerization o f the receptor, PDGF can stimulate
vasoconstriction, mitogenesis, chemotaxis, and other functions in a variety of cells (153,
155).

Various mechanical perturbations including shear stress have been found to

stimulate transcription (64, 65, 66, 115), translation (85), and release (30) of the -AA
homodimer in both endothelial and smooth muscle layers. Shear stress-mediated PDGF-A
induction and subsequent migration and proliferation o f SMCs and fibroblasts
corroborates with the “response to injury hypothesis o f atherogenesis” proposed by Ross
(154). Increased shear stress may be sensed as an insult by the endothelial and smooth
muscle layers, which can respond by synthesizing and secreting growth factors
contributing to atherogenesis and formation o f intimal and medial neoplasias.

As

discussed in previous chapters, the experimental model employed in the current study
induces an increase in in vivo blood flow leading to EC and SMC hyperplasia and vessel
wall remodeling. The aim o f this and subsequent chapters is to determine the role of
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various biochemical growth factors in this flow-mediated vascular remodeling.
Specifically, this chapter examines PDGF-A mRNA expression in control and high flow
vessels using m situ hybridization approaches.
Results
In situ hybridization data for medial wall SMC PDGF-A mRNA expression are
illustrated in Figure 9-1. A highly significant (+215%) increase in medial PDGF-A mRNA
is indicated for the high flow ileal artery after 24 hours. This increase becomes non
significant after 3 (+122%) and 7 (+42%) days as the values decline towards control
levels. An elevated basal expression o f medial PDGF-A mRNA in the ileal artery remains
constant with time. No significant differences between control and high flow vessels were
detected for the second-order artery at any time. Figure 9-2 shows in situ hybridization
data for endothelial PDGF-A mRNA expression. The ileal artery shows a non-significant
(+39%) increase in EC levels after 24 hours which becomes significant after 3 (+129%)
and 7 (+182%) days. No significant differences were detected between control and high
flow second-order arteries; however, data for this vessel were somewhat noisy and
resulted in irregular control values. Figure 9-3 contains autoradiographs for PDGF-A
mRNA expression for same animal sense and anti-sense control and high flow vessels.
Discussion
The most obvious result from this chapter is the highly significant upregulation of
ileal artery medial PDGF-A expression after exposure to increased blood flow for 24
hours (Fig. 9-1). According to the results discussed in previous chapters, once the flow
stimulus was established in this model, significant EC hyperplasia occurred after 24
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Figure 9 - I. Medial SMC PDGF-A mRNA Expression. Medial wall SMC PDGF-A
mRNA expression for control and high flow ileal and second-order branch vessels after in
situ hybridization with 35S-CTP riboprobe and development of silver grain emulsion after
10 weeks. PDGF-A mRNA expression is significantly elevated in the ileal artery after 24
hours, and then gradually declines towards normal levels by 3 and 7 days. Basal levels of
PDGF-A mRNA expression are evident in the control ileal artery.

No significant

differences were detected between control and high flow second-order arteries, and
control level of expression in these vessels was low. Values represent mean ± SEM, and
n = 9 for the ileal artery group and n = 7 for the second-order artery group.
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Figure 9-2. Endothelial PDGF-A mRNA Expression. Endothelial PDGF-A mRNA
expression for control and high flow ileal and second-order branch vessels after in situ
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10
weeks. PDGF-A mRNA expression is significantly elevated in the ileal artery endothelium
after exposure to high flow for 3 and 7 days. No significant differences were detected
between control and high flow second-order arteries, with specific signal similar to
background levels. Values represent mean ± SEM, and n = 10 for the ileal artery group
and n = 7 for the second-order artery group.
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hours with subsequent SMC hyperplasia and luminal and medial wall remodeling after 3
and 7 days. The significant upregulation o f PDGF-A mRNA in the ileal artery media after
24 hours strongly suggests its involvement in flow-mediated vascular remodeling.
Autocrine growth stimulation by PDGF has been characterized by several investigators
(115, 154, 185). Indeed, autocrine mitogenicity from PDGF-A seems to be involved in
the current model, as early medial expression precedes subsequent medial SMC DNA
synthesis, cellular hyperplasia, and medial wall hypertrophy. An opposing proposal was
offered by Vlodavsky et al. (184), who suggested that PDGF exerts its mitogenic action in
a paracrine mechanism to affect neighboring cells within the vessel wall. In the current
model, perhaps elevated medial PDGF-A is stimulating neighboring ECs to multiply.
Although not specifically analyzed in this study, medial PDGF-A protein levels are most
likely elevated after 3 and 7 days o f elevated flow.

Results showing no significant

differences between control and high flow second-order branches are somewhat confusing,
although heterogeneity in vascular growth responses between different orders of vessels as
well as between components o f a single vessel has been characterized by Daemen and De
May (32) and Bobik and Campbell (18).
Basal levels of PDGF-A mRNA expression are evident in this study for the ileal
artery media. This would corroborate the findings of Majesky and coworkers (104, 106)
who found PDGF-A mRNA constitutively expressed in quiescent normal newborn and
adult rat aortic and carotid artery SMCs. In addition, Majesky et al. (106) found basal
levels of transcripts for PDGF receptor subunits, indicating that the normal vessel wall has
the potential to synthesize and respond to both basal and increased levels o f PDGF.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

107

Endothelial PDGF-A mRNA expression was detected preferentially in the high
flow ileal artery after 3 and 7 days (Fig. 9-2). This result is interesting considering that
rapid EC replication occurred after 24 hours (Figs. 6-10, 6-11). If the flow-mediated
stress stimulus was sensed immediately by the endothelium and transferred to subjacent
medial SMCs through cell-cell contacts (matrix proteins, focal adhesion sites), then medial
expression of PDGF-A could occur after 24 hours as shown. Then, through an autocrine
positive feedback loop (154), endothelial expression could subsequently be stimulated by 3
and 7 days resulting in EC hyperplasia. Alternatively, this delayed increase in EC PDGFA transcription could indicate repair of a shear stress-injured endothelium, as suggested by
Majesky et al. (106) who showed increased SMC PDGF-A mRNA 2 weeks after arterial
balloon injury. However, this does not account for the relatively small increase (+39%) in
EC PDGF-A mRNA observed after 24 hours. Perhaps the cellular machinery involved in
initially sensing the stimulus and starting the signaling cascade leading to nuclear
transcription was delayed, as the percentage of PDGF-A mRNA steadily increases at 3
and 7 days.
PDGF-A may act through an autocrine mechanism to induce synthesis of medial
ECM evidenced in this study (Chapter 7). Ross (154) suggested that growth factors
induce synthesis of underlying extracellular connective tissue components in vitro. The
ECM is capable o f regulating storage and release of growth factor peptides (referenced in
41); therefore, enhanced expression of medial PDGF-A evidenced in this study could
reasonably translate into elevated protein levels, followed by sequestration in the ECM
and subsequent autocrine stimulation of cellular and extracellular factors.
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An early catalyst for SMCs to proliferate when exposed to an injuring stimulus
involves increased PDGF-A transcription, as determined by Majesky et al. (106) using a
rat carotid balloon catheter injury model. PDGF-A mRNA levels were elevated 10- to 12fold 6 hours after balloon injury in carotid SMCs. This transient increase in SMC PDGFA mRNA directly preceded entry into the synthetic phase of the cell cycle. Interestingly, 2
weeks after wounding neointimal SMCs expressed elevated PDGF-A transcripts and
protein levels while expression in subjacent SMCs had returned to normal. This suggests
that PDGF-A plays dual roles in response to arterial injury: first, an immediate
upregulation occurs in order to mediate chemotaxis and cellular and extracellular
proliferation directly in response to the injury, and second, a chronic elevation of PDGF-A
occurs as part of the regeneration process and arterial repair.
In conclusion, early medial and subsequent endothelial expression of PDGF-A
mRNA in ileal arteries exposed to flow-associated stresses in vivo may contribute to the
cellular replication and vessel wall remodeling observed in this study.

Temporal and

autocrine regulation o f this growth factor is implied, as significant medial expression after
24 hours contributed to subsequent endothelial expression after 3 and 7 days.

Basal

transcription of PDGF-A was observed in the media o f the ileal artery, supporting the
findings o f previous investigators. However, characterizing the in vivo regulation o f this
growth factor, in terms of shear stress responsiveness and interaction with other factors,
cytokines, and extracellular components, necessitates further examination.
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CHAPTER X
PLATELET-DERIVED GROWTH FACTOR-B CHAIN IS NOT INVOLVED IN
FLOW-INDUCED VASCULAR REMODELING

Introduction
The physiologic actions of PDGF in the vasculature are well established.
Expression of the PDGF-B chain has been associated with medial SMC proliferation and
migration leading to intimal thickening (74), chemotaxis and vasoconstriction (124), and
stimulation of other growth-regulatory genes and mesenchymal cells producing
extracellular components (18). In normal arteries, a low level o f basal expression exists
for PDGF-B in the media with higher levels found in the endothelium (192). The influence
o f physiologic stresses such as vascular injury and repair (81, 106), cyclic strain (193) and
shear stress (66, 107, 118, 147) can significantly alter PDGF-B transcription and
translation. Shear stress upregulation o f PDGF-B mRNA has been shown in cultured ECs
from several sources (64, 66, 118, 147). Elevated levels of PDGF-B peptide were also
found in cultured SMC exposed to cyclic strain (193). In contrast, Malek et al. (107)
found that shear stress significantly downregulated PDGF-B mRNA in cultured BAECs.
In this same study, however, cyclic strain was found to have no effect on PDGF-B
expression.
In the current study as discussed in the previous chapter, early medial and
subsequent endothelial expression of PDGF-A mRNA was significantly upregulated after
exposure to elevated blood flow. The aim o f this current chapter is to further analyze the
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contribution o f PDGF in flow-induced vessel wall remodeling through in situ hybridization
analysis of PDGF-B mRNA transcription.
Results
Figure 10-1 illustrates data from in situ hybridization for medial PDGF-B mRNA
expression. An elevated baseline level o f medial PDGF-B expression is noted especially in
the ileal artery. No significant differences were detected between control and high flow
vessels at any time in both ileal and branch arteries. Expression o f PDGF-B in the ileal
artery media after 7 days is elevated in both the control and high flow vessels when
compared to I and 3 day vessels. Figure 10-2 shows data for endothelial expression of
PDGF-B. Significant increases (+62%) are evident in the ileal artery after 7 days. No
other significant differences were detected between control and high flow vessels. Again,
a basal level o f endothelial PDGF-B expression is shown, especially in the ileal artery
endothelium. Basal levels in the second-order artery are relatively low. Figure 10-3
illustrates autoradiographs for PDGF-B mRNA expression for same animal sense and anti
sense control and high flow vessels.
Discussion
As discussed in Chapter S, the primary flow-induced stimulus in this model was
determined to be shear stress with possible involvement o f stretch-induced wall stress in
the ileal artery. These flow-associated stresses had no impact on medial wall expression of
PDGF-B mRNA (Fig. 10-1), suggesting that medial wall PDGF-B is not involved in the
flow-regulated arterial remodeling observed in this study.

However, a significant

upregulation o f endothelial PDGF-B mRNA was apparent after exposure to elevated flow
for 7 days (Fig. 10-2). This is in agreement with the findings of several other investigators
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Figure 10-1. Medial SMC PDGF-B mRNA Expression. Medial wall SMC PDGF-B
mRNA expression for control and high flow ileal and second-order branch vessels after in
situ hybridization with 35S-CTP riboprobe and development o f silver grain emulsion after
10 weeks.

No significant differences were detected between control and high flow

vessels at any time. Transcript levels o f both control and high flow ileal arteries were
elevated after exposure to elevated flow for 7 days. Basal production o f PDGF-B mRNA
is noted for both the ileal and second-order arteries. Values represent mean ± SEM, and
n = 8 for the ileal artery group and n = 6 for the second-order artery group.
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Figure 10-2. Endothelial PDGF-B mRNA Expression. Endothelial PDGF-B mRNA
expression for control and high flow ileal and second-order branch vessels after in situ
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10
weeks. A significant increase in ileal artery PDGF-B mRNA occurred after exposure to
flow for 7 days, while no other significant differences were detected at any time. An
elevated basal level o f PDGF expression is obvious in the ileal artery endothelium.
Values represent mean ± SEM, and n = 8 for the ileal artery group and n = 6 for the
second-order artery group.
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who demonstrated shear stress increased the endothelial expression o f PDGF-B in
cultured cells (64, 66, 118, 147). In comparison, these studies were generally short-term,
and PDGF-B upregulation was transient with a subsequent reduction towards basal levels.
In the current study, only chronic exposure to flow-associated stresses resulted in a
significant upregulation o f endothelial PDGF-B message. This result is rather counter
intuitive considering that immediate EC replication occurred after 24 hours (Figs. 6-9, 610). The lack o f early induction o f endothelial PDGF-B after exposure to increased flow
for 1 and 3 days suggests that perhaps the endothelium requires a prolonged time for
sensing flow-associated stresses and may be specific for the arteries used in this
experimental model.
Autocrine growth stimulation by PDGF has been characterized by several
investigators (115, 154, 185). However, autocrine mitogenicity from PDGF-B does not
seem to be involved in the current model, considering that differences were not detected
between control and high flow vessels yet the high flow vessels experienced significant
cellular hyperplasia and vessel wall hypertrophy. Only after 7 days of elevated flow does
the endothelium exhibit significant PDGF-B expression (Fig. 10-2).

According to

Vlodavsky et al. (184), PDGF exerts its mitogenic action in a paracrine fashion affecting
neighboring cells within the vessel wall. In the present study, elevated PDGF-A mRNA
expression in the vessel media after 24 hours could reasonably act through a paracrine
loop to induce subsequent endothelial transcription o f PDGF-B chain after 7 days.
Endothelial expression of PDGF-A chain was elevated after 3 and 7 days (Fig. 9-2),
supporting evidence for this proposed feedback loop initially stimulated by medial PDGFA mRNA.
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A basal level o f medial and endothelial PDGF-B expression was evident in this
study, consistent with findings in cultured SMCs (125, 163) and ECs (64, 65, 66).
Majesky et al. (106) suggested this constitutive expression o f PDGF may allow normal
vessels to synthesize and respond to both basal and increased levels of PDGF in order to
maintain a normal cellular environment.
In conclusion, results from this chapter do not implicate medial or endothelial
PDGF-B expression in regulating the flow-induced arterial remodeling observed in this
study. Expression o f endothelial PDGF-B message became significant only after exposure
to flow for 7 days and was not involved in the earlier SMC or EC mitogenic events. Basal
levels of both medial and endothelial PDGF-B mRNA were detected, providing support
for its role in maintaining vascular homeostasis.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

116

CHAPTER XI

NEITHER bFGF NOR TGF-01 CONTRIBUTE TO VESSEL WALL
REMODELING FROM INCREASED BLOOD FLOW

Introduction
As discussed in the previous chapters, PDGF is a vital growth factor capable of
mediating vasoconstriction, chemotaxis, mitogenicity, and various other homeostatic and
pathophysiologic functions in a variety of cell types. PDGF-A mRNA expression was
found to be stimulated by flow-associated stresses possibly contributing to flow-induced
vessel wall remodeling under in vivo conditions. Several other growth-regulating factors
including bFGF and TGF-Pl have been implicated in the etiology of abnormal arterial
growth and vascular remodeling.

Basic FGF has important properties that readily

influence migration and growth of vascular cells.

Since bFGF has no obvious signal

sequence (18), its secretion is thought to occur in combination with carrier proteins,
through interaction with ECM proteins (22, 149, 158), or through disruption of the
plasma membrane in cell lysis during vascular injuries (30). Mechanically-injured SMCs
were found to release biologically active bFGF into the medium that was cytosolic in
origin and not dependent on ECM-release (30). Significant release of bFGF was found in
rat iliac veins exposed to elevated arterial flows from bypass grafting, suggesting a role for
bFGF in stimulating myointimal hyperplasia after bypass surgery (161).

Shear stress-

induced alterations in bFGF transcription (107) and protein release (172) have also been
characterized in cultured ECs and SMCs. The first goal o f this present chapter is to
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characterize the contribution o f endothelial and smooth muscle bFGF expression in
mediating flow-induced vessel wall remodeling under in vivo conditions.
Transforming growth factor-P 1 exerts multiple effects on the vascular environment
which depend on various parameters such as the presence o f cytokines or other growth
factors and on the stage of cellular differentiation. Owens et al. (135) observed TGF-p 1
to inhibit SMC hyperplasia by increasing cell cycle time while concurrently inducing
cellular hypertrophy by increasing accumulation of cells in the G2 phase o f the cell cycle.
Gibbons and co-workers (53, 83) found All stimulated conversion o f the latent inactive
form of TGF-P 1 to a biologically active form which induced SMC hypertrophy. Presence
of the latent inactive form of TGF-P 1 resulted in SMC hyperplasia.

TGF-P 1 is also

capable of autocrine stimulation o f its own transcription in a positive feedback loop in
normal and transformed cultured cells (182). TGF-P 1 plays a role in stimulating synthesis
of ECM components (71, 150).

This growth factor has also been implicated in

morphogenesis of fibroblasts, mitogenesis of osteoblasts and Schwann cells, and
chemotaxis of fibroblasts and monocytes (reviewed in 161).

Shear stress stimulated

transcription and production of TGF-P 1 has been characterized in cultured endothelium by
Ohno et al. (128, 129, 131).

The second goal of this chapter is to characterize the

contribution of endothelial and smooth muscle TGF-P 1 expression in mediating flowinduced vessel wall remodeling under in vivo conditions.
Results
In situ hybridization data for medial wall and endothelial bFGF mRNA are
graphically illustrated in Figures 11-1 and 11-2. No significant differences were detected
between control and high flow vessels at any time in either the media or the endothelium.
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Figure 11-1. Medial SMC bFGF mRNA Expression. Medial wall SMC bFGF mRNA
expression for control and high flow ileal and second-order branch vessels after in situ
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10
weeks. No significant differences were detected between control and high flow vessels at
any time point. Medial SMC basal levels of expression were negligible for both ileal artery
and second-order branch. Values represent mean ± SEM, and n = 8 for the ileal artery
group and n = 6 for the second-order artery group.
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Endothelial bFGF mRNA Expression.

i

7

Endothelial bFGF mRNA

expression for control and high flow ileal and second-order branch vessels after in situ
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10
weeks. Endothelial bFGF expression was quite minimal, with no significant differences
detected between control and high flow vessels. Values represent mean ± SEM, and n =
8 for the ileal artery group and n = 6 for the second-order artery group.
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Figure 11-3. Autoradiographs for bFGF mRNA Expression.
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Medial and endothelial expression o f bFGF in the ileal artery and second-order branch
were quite low. Figure 11-3 contains autoradiographs for bFGF mRNA expression for
same animal sense and anti-sense control and high flow vessels. Figures 11-4 and I l-S
show medial and endothelial expression of TGF-P 1, respectively. Similarly, most time
points indicate low expression of TGF-P 1 expression; however, ileal artery medial
expression is significantly increased for high flow vessels compared to controls after 7
days (Fig. 11-4). An interesting but statistically insignificant upregulation of TGF-P 1 is
observed in both control and high flow second-order arteries after 24 hours in the media
and endothelium. Figure 11-6 shows autoradiographs o f TGF-P 1 expression for same
animal sense and anti-sense control and high flow vessels.
Discussion
Results from in situ hybridization reveal low basal and flow-induced levels of
expression of bFGF in vivo (Figs. 11-1, 11-2). Low levels of basal expression of bFGF
have been documented elsewhere (18, 75); however, shear stress was found to upregulate
bFGF mRNA and protein release in cultured BAECs (107, 172). Basic FGF peptides are
predominantly associated with the ECM, and release can be stimulated by proteolytic
enzymes (22). According to Baird and Ling (18), a major determinant of bFGF-induced
neovascularization is not expression of the factor but the presence o f these extracellular
enzymes.

In the current study as discussed in Chapter 7, flow-associated stresses

stimulated increased extracellular connective tissue.

Accordingly, flow could also

stimulate increased production of extracellular enzymes, although no studies have focused
on this to date. In the current study, bFGF expression was insignificant in mediating flowinduced remodeling in small arteries. In addition, cells generally increase transcription of
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Figure 11-4. Medial SMC TGF-p 1 mRNA Expression. Medial wall SMC TGF-p 1
mRNA expression for control and high flow ileal and second-order branch vessels after in
situ hybridization with 35S-CTP riboprobe and development of silver grain emulsion after
10 weeks. Ileal artery basal expression was not observed, and a significant increase in high
flow occurred after exposure to flow for 7 days. No other differences were detected
between control and high flow vessels at any time. Interestingly, both control and high
flow second-order arteries had elevated levels o f TGF-P 1 expression after 24 hours, and
both decreased by 3 and 7 days. Values represent mean ± SEM, and n = 7 for the ileal
artery group and n = 6 for the second-order artery group.
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Figure 11-5. Endothelial TGF-P 1 mRNA Expression. Endothelial TGF-P I mRNA
expression for control and high flow ileal and second-order branch vessels after in situ
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10
weeks. No significant differences were detected between control and high flow vessels at
any time. Overall expression in the ileal artery was quite low. Both control and high flow
second-order arteries experienced elevated levels of TGF-P 1 expression after 24 hours,
and both decreased by 3 and 7 days. Values represent mean ± SEM, and n = for the ileal
artery group and n = for the second-order artery group.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

124

control, sense

control, anti-sense

♦

high flow; sense

high flow, anti-sense

•%

Figure 11-6. Autoradiographs for TGF-P 1 mRNA Expression.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

125

various growth factors when under culture conditions when compared to the in vivo state
(18), so direct extrapolation of in vitro to in vivo results requires prudence.
The influence of TGF-P 1 in mediating flow-induced vessel wall growth in the
current model was negligible. Basal levels of TGF-P 1 expression were low in both ileal
and second-order arteries, although the smaller branch experienced increased expression
after 24 hours in both control and high flow vessels.

The ileal artery experiences a

significant increase in medial TGF-P 1 expression after exposure to flow for 7 days. Since
TGF-P 1 has been shown to be upregulated with shear stress (128, 129, 131), and
considering that TGF-P 1 can auto-stimulate its own message (182), perhaps after 7 days
significant increases in self-stimulated expression are finally achieved (Fig. 11-4). The ileal
artery at this time point is undergoing significant DNA replication and cellular hyperplasia
(Figs. 6-6, 6-8, 6-9), which would correlate with the presence o f a latent inactive form of
TGF-P 1 peptide. Also, TGF-P I has been found to stimulate syntheses of extracellular
fibronectin and collagen (71, 150), as well as their incorporation into the ECM (71). In
the current model, however, TGF-P 1 does not seem to be involved in increased synthesis
of the extracellular connective tissue observed (Fig. 7-1). Generally speaking, the role of
TGF-P 1 in mediating flow-induced medial wall hypertrophy observed in this in vivo model
is minimal.
In conclusion, results from this chapter imply that bFGF and TGF-P I were not
directly involved in the flow-mediated vessel wall remodeling observed under in vivo
conditions. Elevated medial wall TGF-P 1 expression after 7 days suggests the possibility
of autocrine

stimulation

of

TGF-P 1

transcription

in

flow-exposed
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CHAPTER XH
CONCLUSIONS AND INFERENCES

The investigation discussed in these chapters details a unique experimental model
that allows molecular and histologic analyses of arterial wall remodeling in response to
altered hemodynamic parameters under in vivo conditions. The primary stimulus in this
model was flow-induced shear stress with possible contribution from stretch-induced wall
stress in the ileal artery. Flow-induced luminal expansion and medial wall hypertrophy
occurred in deal and second-order branching arteries in a time-dependent fashion over a 7
day period. These structural adaptations involved early and dramatic EC hyperplasia after
24 hours with subsequent medial SMC DNA replication and hyperplasia after 3 days.
These medial wall changes also involved a concomitant increase in extracellular connective
tissue.
Nitric oxide is suggested as a possible signaling factor in these flow-mediated
arterial alterations. Early medial and subsequent endothelial PDGF-A mRNA expression
possibly contributes to SMC and EC replication and vessel wall remodeling. Expression
of medial and endothelial PDGF-B, bFGF, and TGF-P 1 was not significantly affected by
flow-associated stresses in this model, and their roles in mediating the flow-induced
alterations observed are believed to be minimal.
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